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Abstract 
This thesis aims to rationally design semiconductor nanoparticles and metal-
semiconductor core-shell nanomaterials and investigate their potential as 
fluorescent probes for bio-imaging applications. Inorganic semiconductor 
nanoparticles are considered promising fluorescent probes for biological 
imaging, as they offer various advantages over their conventional organic 
fluorescent molecules including bright emission, photostability and low power 
excitation. To use these materials for biological imaging, these nanomaterials 
need to be biocompatible and emit in the near-infrared (NIR) region, where the 
auto-fluorescence contributions from the biological samples are minimum. 
Among the various semiconductor nanomaterials, Cu2O nanomaterials are 
chosen for the present study. This is a p-type direct bandgap semiconductor 
material (2.17 eV in bulk form), which can be synthesized in a wide range of 
morphologies such as nanocubes, nanospheres, nanorods and nano 
octahedrons. To date, these nanoparticles have not been greatly studied as 
fluorophores and they have never been optimised for biological imaging studies. 
Therefore, the first major objective of the thesis was to obtain Cu2O nanocubes 
with uniform size and high yield.  The nanocubes were synthesized using the 
seed-mediated approach where the presence of capping agent, sodium dodecyl 
sulfate (SDS) during synthesis plays a key role to stabilise these nanocubes 
and two major modifications during the synthesis led to the formation of uniform 
sized nanocubes. Controlling the ageing time of the seeds and the 
concentration of the precursors were the key parameters that enabled 
nanoparticles to be fabricated with a uniform shape and a high yield.  
Subsequently, the fluorescent properties of these uniform size Cu2O nanocubes 
were investigated to study their suitability for bioimaging applications. The 
nanocubes are used in this study are 293 ± 18 nm along one side on average. 
These nanocubes exhibit strong emission in the NIR region, which is highly 
desirable for bioimaging applications due to the reduced autofluorescence from 
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the biological samples in this spectral region. This strong NIR emission was 
observed to shift at lower temperatures and their emission wavelength and 
intensity can also be tuned as a function of temperature. Oxygen vacancies and 
their defect structures were found to be responsible for their emission in the NIR 
region. Their brightness and photostability were found to be extremely suitable 
for biological applications. Individual Cu2O nanocubes were studied using a 
marked substrate which was milled with a focused ion beam to locate and 
collect optical data from 19 individual particles. This study reveals that single 
Cu2O nanocube can emit light with counts up to 487K counts/s for at least 120 
seconds with only 11 µW (1.7 W/cm2) laser excitation. Highly bright and 
photostable intrinsic fluorescence from Cu2O nanocubes at low excitation 
powers suggests that the nanocubes are suitable for long time bioimaging 
experiments. Lifetime measurements of individual nanocubes were estimated 
and found to have two component lifetimes. This property could also be 
advantageous for lifetime-based imaging applications using these 
nanoparticles. 
For testing these materials for bio-imaging applications, cell viability of these 
nanomaterials was carried out on HEK293 cells and BV2 cells and it was 
observed that cell viability was not significantly influenced by nanoparticle 
incubation regardless of the incubation period, cell type or nanoparticle 
concentration. 
An LDH (Lactate dehydrogenase) activity test was also carried out on both 
HEK293 cells and BV2 cells. For this study, HEK293 cells did not exhibit any 
significant concentration-dependent increase in cytotoxicity at any time point. 
For BV2 cells, LDH activity has not elevated after 2 hours of incubations with 
Cu2O nanocubes regardless of the Cu2O concentration for BV2 cells. However, 
after 24 hours of incubation with Cu2O nanocubes for BV2 cells, for 4 µg/mL 
and 2µg/mL, LDH activity largely increased, although cells that are treated for 2 
hours then washed and kept for 22 hours for regular incubation showed much 
lower LDH activity for these two concentrations compared to 24 hours 
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incubations. This study suggests that concentration-based cytotoxicity highly 
depends on cell types and not all cell types show cytotoxicity towards Cu2O 
nanocubes. For phagocytic cells, short-term incubation such as for 2 hours, 
nanoparticles concentrations up to 4 µg/mL can be used. In the case of a long-
term incubation, such as 24 hours, less than 500 ng/mL is suggested for this 
cell type.  
The attractive optical properties from Cu2O nanomaterials can be combined with 
NIR absorbing plasmonic gold nanorods in the form of their AuNR and Cu2O 
core-shell nanoparticles, which are another potential candidate nanomaterial for 
the bioimaging applications. The synthesis method for these particles involved 
the formation of a Cu2O shell on the surface of gold nanorods which enables 
control of the thickness of the shell. The capping agent, SDS was used during 
synthesis for the stabilisation of these nanoparticles. SEM and TEM analysis of 
these materials clearly demonstrated the formation of core-shell nanoparticles 
where the average length of this Au(rods)@Cu2O core/shell nanoparticles is of 
80.6±10 nm with 25.6 ± 3.5 nm average shell thickness, while the optical 
properties show the combination of fluorescent and plasmonic characteristics.  
This data shows that the fluorescence properties of Au nanorods can be 
enhanced remarkably due to plasmon-exciton interactions after Cu2O shell 
formation on the surface. 
Overall, synthesised Cu2O nanocubes were demonstrated to have highly bright 
and photostable emission, with temperature dependent tunability of emission 
spectra and brightness.  In addition, possessing an ability to enhance 
fluorescence properties through plasmon-exciton interactions, combined with 
the positive biocompatibility results, enable these materials as desirable 
candidates for future bioimaging applications in areas such as angiogenesis. 
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1.1 Introduction 
Optical imaging is explicitly the most useful and broadly used visualization 
modality used in research and laboratory diagnosis[1-3]. The observation of a 
biological sample using an optical microscope is the major pathway to 
laboratory diagnosis. New technologies are continuously emerging in the field 
of microscopy which also significantly contribute to the progress of biology and 
medical sciences[1, 2, 4-15]. Fluorescence microscopes are widely used in the 
field of biomedical research because of their contrast mechanisms which give 
rich information on the photochemical process, sometimes at a molecular level 
during light-tissue interactions or light and exogenous label interactions[16]. 
Fluorescence microscopes are even getting more popular in recent years due 
to the availability of a wide range of fluorescent probes and an increasing 
interest in developing new fluorescent dyes and nanomaterials. 
Fluorescence imaging is also a popular tool to image at the macroscopic level 
where a whole body of a small animal is imaged instead of imaging cells on 
slides or well plates. This imaging technique gives more accurate information 
as the images are taken when these animals are alive so that their physiological 
state remains intact[1]. However, the challenges for the in vivo imaging include 
the emission of a strong autofluorescence from the animal tissue and the 
requirement of a fluorescent probe which is specific to the target and gives good 
contrast while imaging[17]. In the following sections of the introduction, the 
basic principle of fluorescence, confocal microscopy, available fluorescence 
probes and motivation of this thesis are described. 
 3 
 
1.2 Fluorescence in biological imaging 
Fluorescence, the photophysical phenomenon is defined as “spontaneous 
emission of radiation ( luminescence) from an excited molecular entity with 
retention of spin multiplicity”[18]. Absorption and scattering are the two major 
interaction between the light and matter and fluorescence is one-kind of a 
photophysical phenomenon that occurs immediately after the light absorption 
as shown in Figure 1-1. There are several types of luminescence such as 
photoluminescence, electroluminescence, bioluminescence and 
sonoluminescence, and fluorescence is a type of luminescence that falls under 
photoluminescence (Figure 1-1)[19]. Luminescence, this generic term describe 
any kind of light emitting photophysical phenomena that generally refers to 
“spontaneous emission of radiation from an electronically excited species or 
from a vibrationally excited species, which are not in thermal equilibrium with its 
environment” [18, 19].  
 
Figure 1-1: Light-matter interaction and their possible physical effects. Reprinted 
with permission from ref[19]. 
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When a molecule absorbs a photon after excitation, an electron moves to the 
higher electronic state from the ground electronic state. However, the excited 
state of the molecule is temporary, as this state is not in thermal equilibrium with 
other molecules. Therefore, it relaxes back into the ground electronic state by 
emitting a light photon. This emission is termed as fluorescence when it occurs 
in the singlet system (Figure 1-2).  
 
Figure 1-2: Energy diagram of showing the absorption of energy after excitation 
and emission of energy as fluorescence or phosphorescence. Fluorescence and 
phosphorescence occur from the singlet system and triplet system, respectively. 
Reprinted with permission from ref[20]. 
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However, light emission from a triplet excited state to a ground electronic singlet 
state is referred to as phosphorescence (Figure 1-2). The time scale of each 
phenomenon occurs at a different time followed by light absorption as shown in 
Figure 1-2[20, 21].  
The original observation of fluorescence was first reported by Nicolas Monardes 
in 1565 and then in 1853, the term fluorescence was first introduced by Sir 
George Gabriel Stokes. According to Stokes’ law, the fluorescence spectrum or 
emission wavelength is always positioned at a longer wavelength (lower 
energy) than the excitation wavelength as this excited species loses some 
energy in the excited state due to the vibrational relaxation[19, 20]. This gap 
between the first excitation or absorption band and the emission band is called 
the Stokes shift (Figure 1-3)[20]. 
 
Figure 1-3: Example of stoke shift for a typical fluorescence compound. 
Reprinted with permission from ref[19, 20]. 
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Fluorescent-based optical imaging involves either insertion of an exogenous 
gene to a sample that produces fluorescent protein or administration of a 
fluorescent probe to sample that targets a receptor, or an enzyme specifically 
to observe the fluorescent signals through a fluorescence microscope[20, 22].  
Cell imaging using fluorescent microscopy have seen significant progress 
because it is possible to label specific cells, or cellular components with different 
fluorophores and image them using a fluorescence microscope[14, 20, 22-27].  
For fluorescence imaging, it is important to know the Stokes shift (Figure 1-3) 
of the fluorescence probes, as Stokes shift less than 70 nm can cause 
reabsorption of emitted photons which can lead to an undesirable background 
interference[28]. 
 
1.3 Fluorescence probes for biological imaging 
applications 
Biological imaging using fluorescent probes enables the visualization of cellular 
function, the therapeutic action of a drug, gene therapy and monitoring the 
multiple biomolecular processes much easier than conventional microscopes 
as they provide incredibly rich information[20, 24]. Due to the discovery of a 
wide range of fluorescence tags, the anatomical localisation of proteins and the 
imaging of dynamic cellular functions becomes possible[29]. Fluorescent 
probes in biological imaging can be divided into two major categories[1, 2]. The 
first kind is called direct imaging that is fluorophore based optical probes, which 
are either organic dyes having the fluorescent properties or inorganic 
semiconductor or quantum dots[1, 2]. The second category of optical probes is 
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called indirect imaging that uses transgene or the reporter gene and when this 
gene expressed, it produces fluorescence proteins[22]. With this method, gene 
translation can be imaged and quantified indirectly. Fluorescence probes are 
routinely used in tagging proteins through immunolabelling which is an example 
of direct imaging[30] and through genetic encoding which is a type of indirect 
imaging[31-33] technique to study protein activity and protein expression[29] 
(Figure 1-4).  
 
 
Figure 1-4: Application of different types of fluorescent probes used for tagging 
proteins (A, B, D and E). Structure of those fluorescent probes and their 
targeting proteins (C). Scale bars in (A), (B), and (D), 20 mm (LM); (B), 50 nm 
(EM); (C), 2 nm; (E), 2 mm. Reprinted with permission from ref[29].  
 
A major objective of the thesis is to utilize inorganic semiconductors for 
biological imaging, which fall under the direct fluorescent imaging category. 
Hence, indirect imaging is not discussed in this thesis as it is beyond the scope 
of the thesis. A wide variety of organic dyes[28, 34, 35], inorganic 
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semiconductor nanoparticles[36-39], quantum dots[40-43] and up-converting 
nanoparticles[44, 45] have been used for biological imaging applications. For a 
fluorescent probe to be considered for biological imaging, Stokes shift, 
photostability and an ability to emit with low power excitation are very important 
attributes expected from the probes to obtain high-resolution imaging[28, 46, 
47]. These attributes will be discussed in further detail in the remaining part of 
this Chapter. One of the powerful tools of biological imaging is confocal 
microscopy. A brief overview of the confocal microscope is given in the next 
section.   
 
1.4 Overview of confocal microscopy 
Confocal microscopy is a widely used imaging tool biology because it allows 
high-quality imaging through controlling the depth of field of an imaging 
specimen and eliminating background information which is far from the focal 
plane[48].  
Confocal Laser fluorescence microscopy is mainly used for such biological 
imaging using any of the afore-mentioned fluorescent probes.  Three-
dimensional resolution can be achieved by reducing any signal coming from 
out-of-focus planes. As shown in Figure 1-5, the presence of a pinhole just in 
front of the detector can suppress the signals from out of focus planes. Light 
signals come from the in-focus plane can only pass the pinhole, while the out-
of-focus signals blocked by the pin-hole[49]. Instead of using a broad band light 
source, a monochromatic laser generally illuminates the sample in a confocal 
fluorescence microscope. Upon laser illumination, the fluorophore excited by 
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absorbing the photons and cause fluorescence, which is the major mechanism, 
by contrast, can be generated. Experimentally, the laser light come out of the 
excitation pinhole focused on the part of the specimen using dichroic mirror and 
an objective lens. The choice of dichroic mirrors is based on the relevant 
wavelength regions of excitation and fluorescence.  
 
Figure 1-5: A typical confocal microscope[49]. 
 
1.5 Organic dyes as Fluorescence probes for biological 
imaging  
Organic molecules which fluoresce are powerful tools which can be used to 
image the cellular organelles and processes at the molecular level[3]. Currently, 
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a range of fluorescent organic probes is available that is used for metal ions 
sensing, pH sensing and to study enzyme activities[14].   
After quinine  (Figure 1-6 a) was introduced as a fluorophore, which has a blue 
emission with ultraviolet light excitation, a wide range of organic compounds 
were discovered or created that emit from the visible spectrum to the near 
infrared region and many of them are used for immunofluorescence or 
immunolabelling techniques[19, 20].  
 
Figure 1-6: Chemical structures of some popular organic fluorophores. a) 
Quinine sulfate, b) fluorescein and 2-Me TG , c) rhodamine B, d) 1,3,5,7-
tetramethyl-8-phenyl-BODIPY, e) indocyanine green, f) 2-Me TM, and g) 
photochromic rhodamine. Reprinted with permission from ref[14].  
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Fluorescein, cyanine dyes, rhodamine dyes and BOIDPY dyes are widely used 
as fluorescent probes for bioimaging and the chemical structures of such dyes 
are shown in Figure 1-6[14, 19, 20, 26-28, 50]. optical properties of different 
commercially available fluorescent dyes are given in Table 1-1. 
 
Table 1-1 Excitation wavelength, emission wavelength and Stokes shifts of 
some commercially available fluorescent dyes[28, 34, 35]. 
 
 
Compounds Excitation or 
absorption max. 
(nm) 
Emission 
Max (nm) 
Stokes 
shift (nm) 
    
Alexa Fluor 350 346 442 96 
Alexa Fluor 488 496 519 23 
Alexa Fluor 555 555 565 10 
Alexa Fluor 790 784 814 30 
Fluorescein 494 518 24 
5-Carboxyfluorescein 484 520 36 
Fluorescein 494 518 24 
Rhodamine 123 502 528 26 
Rhodamine 6G 528 552 24 
Rhodamine Green™ 494 520 26 
Cy2 493 506 13 
Cy3  550 570 20 
Cy5  650 670 20 
Nile red 580 650 70 
BODIPY 493 494 504 10 
BODIPY 505 502 512 10 
Mito-Tracker Green™ 490 516 26 
Mito-Tracker Red™ 579 599 20 
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Among the different fluorescent probes, Alexa Fluor and Cyanine are examples 
of two highly popular organic dyes. Alexa Fluor is available with a large variety 
and a range of excitation or absorption wavelength. For example, this dye is 
available from 346 nm to 784 nm excitation wavelength with an emission band 
from 442 nm to 814 nm [34] (Figure 1-7 and Table 1-1). This dye is used for 
labelling proteins, antibodies, cDNA, RNA and DNA[51].  
 
 
Figure 1-7: Emission spectra for Alexa Fluor dyes[34]. A range of Alexa fluor 
dyes is available which can be excited from 350 nm to 790 nm and have 
emission spanning the spectral range from around 400 nm to 800 nm. 
 
Although different types of Alexa Fluor dyes are widely used in biological 
imaging, this fluorescence probe bleaches within a relatively short period of 
time, for example, Alexa Fluor 647 almost completely looses its ability to 
fluoresce within a 40 second time period (Figure 1-8).  
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Figure 1-8: Fluorescence microscopy image of astrocytes labelled with Alexa 
647, showing the photobleaching of Alexa 647 over time. Reprinted with 
permission from ref [52]. 
 
Cyanine is another widely used fluorescence probe which has been used for 
labelling peptides, proteins, antibodies and oligonucleotides. Emission spectra 
of Cyanine dyes are available from 500 nm to 800 nm with different excitation 
wavelengths(Figure 1-9)[35].  
 
Figure 1-9: Emission spectra of Cyanine fluorescent dyes[35]. A range of 
Cyanine dyes is available which have emission from around 400 nm to 800. 
 
Similar to Alexa Fluor, cyanine dyes also undergo photobleaching in a few 
minutes[53] (Figure 1-10).  
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Figure 1-10: Photostability study using Fluorescein and Cyanine dye. The artery 
endothelial cells were labelled with Fluorescein and Cyanine dye (Cy3). The 
images were taken at 30-second intervals up to 210 seconds (0, 30, 90, and 
210 seconds of exposure). The result shows both of the dyes highly bleached 
within 210 seconds[53]. 
 
For the photostability study, the cytoskeleton of bovine pulmonary artery 
endothelial cells were used and labelled with Fluorescein and Cyanine dye and 
the data was taken at 30 seconds interval. This study shows both of the dyes 
highly photobleached with 210 seconds (Figure 1-10) 
In addition to the emission wavelength, it is very important to know the 
photostability of a certain fluorophore. After excitation for a certain time, organic 
fluorophores loses their ability to fluoresce irreversibly which is called 
photobleaching[13, 25] and this is a major drawback in using organic 
fluorophores in biological imaging. 
1.6 Inorganic nanoparticles as Fluorescence probes for 
biological imaging  
As mentioned earlier, there are different kinds of nanoparticles that was 
introduced as a fluorescent prob such as quantum dots, noble metal clusters 
(Au nanoparticles, Ag nanoparticles and platinum nanoparticles), quantum dots, 
upconversion nanoparticles, carbon dots, nanodiamonds, and carbon 
nanotubes[42]. Among them, noble metal clusters are usually 2 nm in diameter 
)[10]. 
 
0 S 90 S 210 S 30 S 
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and there is much similarity is observable between excitation and emission 
band of organic dyes and noble metal clusters. They are sensitive to the local 
environment and their properties are not well studied and rationalised as 
semiconductor quantum dots [42, 54-56]. After organic dyes, quantum dots are 
widely used nanoparticles that have been used for biological imaging because 
they can be detected using conventional microscopy instruments, their photo 
physics is well known and the presence of some functional groups on their 
surface enables site specific-labelling[43].  
Quantum dots show size dependent photoluminescence properties due to 
quantum confinement[57]. Quantum dot can also be used for two photon 
confocal microscopy[41]. Figure 1-11 shows the emission spectra of CdSe 
quantum dots with 365 nm excitation which shifts with the increase of size. 
 
Figure 1-11: Absorption and fluorescence spectra of CdSe quantum dots which 
red shifted with the increase of size. Reprinted with permission from ref [57].  
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However, limitations of using quantum dots for biological applications include 
their toxic nature[58] and photo blinking[59]. Study shows that emission spectra 
of certain types of this material have an on-state and an off-state and this 
blinking in emission spectra increases with the increase of excitation power 
density[59] (Figure 1-12).  
 
Figure 1-12: Fluorescence image of quantum dots showing the on-state (a) and 
off-state (b) during emission. Reprinted with permission from ref [59]. 
 
A group of nanomaterials that have become popular in recent years are carbon-
based nanomaterials[60]. Carbon nanotubes, graphene, carbon dots and 
nanodiamonds are examples of various carbon nanomaterials[60]. Carbon 
nanotubes and graphene show strong absorption in the NIR-I (Near Infrared-I) 
window (Figure 1-13) which can be used for photo acoustic and photothermal 
therapy[61, 62] whereas single-walled carbon nanotubes have emission at NIR-
II window (Figure 1-13) which favours the deep tissue fluorescence imaging[63-
65].  
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Figure 1-13: Biological window, NIR-I (700 nm to 950 nm), NIR-II (1000 nm to 
1350 nm) and NIR-III (1550 nm to 1870 nm). These regions in the 
electromagnetic spectrum give increased transparency towards biological 
samples during fluorescence imaging. Reprinted with permission from ref[66]. 
 
As nondiamond has long fluorescence lifetime, these nanoparticles are very 
useful for time gated imaging[67]. Another class of nanomaterial which absorbs 
light at the NIR region and emits at the visible region is upconversion 
nanoparticles[58]. As these nanoparticles are insoluble in water, for biological 
imaging, they often require silica coatings or other surface functionalisation to 
increase solubility[58]. 
The oxides of copper[36, 37], zinc[38] and titanium[39] also have the potential 
for use in biological imaging systems, an alternative to the previously mentioned 
nanoparticles to circumnavigate their limitations. The origin of these 
nanoparticles fluorescence comes from their defective sites, oxygen 
deficiencies and structural modification[36-39]. This group of nanomaterials has 
not been studied extensively for biological imaging applications except there 
has been some progress with ZnO nanoparticles[38]. In some cases, some of 
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the metal oxide nanoparticles require labelling with fluorescent dyes for 
biological applications[68] (Figure 1-14). Type of metal oxide with strong 
emission properties can be an alternative to those metal oxides which can 
reduce the steps for material processing and eliminate the requirement of 
introducing extra chemicals in the biological systems. Further work is required 
in the choice of inorganic semiconductors for biological applications, especially 
regarding their intrinsic emission properties.  Hence, Cu2O nanoparticles are 
chosen for this study and the characterisation and optimisation of their physical 
and optical properties in relation to future biological imaging applications is the 
primary objective of the current thesis work. 
 
 
Figure 1-14: Confocal fluorescence image of RITC (rhodamine isothiocyanate) 
labelled TiO2 (a) and phenylrhodamine-labelled Al2O3 particles. Scale bar 5 µm. 
Reprinted with permission from ref [68]. 
 
1.7 Copper(I) oxide (Cu2O) Nanoparticles - Introduction 
There are three stable copper-oxide compounds available, such as Cu2O, 
Cu4O3 and CuO. Among them, Cu2O crystallises in a cubic lattice (Figure 1-15). 
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Each unit cell contains four copper atoms and two oxygen atoms where copper 
atoms are located to form a face-centred cubic lattice and oxygen atoms form 
a sub lattice which is body-centred cubic and located at tetrahedral sites[36, 
69].  
 
Figure 1-15: Structure of crystalline Cu2O.Copper atoms are represented by big 
blue spheres and oxygen atoms are represented by the small red spheres 
where coordination of each copper atoms is linear to two oxygen atoms. 
Reprinted with permission from ref [36].  
 
The shape of Cu2O crystals determines by the preferential absorption of the 
additives on the fine particles in a growth solution as these additives tend to 
attach low energy surfaces while high energy surfaces facilitate the growth to a 
certain direction through aggregation[70-72]. There are some reports showing 
that in the synthesis of cubic copper(I) oxide, the capping agent do not only act 
as a growth directing agent but also work as a protective layer for maintaining 
chemical oxidation state of the copper[70-72]. Cu2O is a p- type semiconductor 
material[36, 73-84] and several attempts have been reported to increase their 
efficiency for solar cell applications. By combining this material with other 
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semiconductors, electronic and optical properties of this material can be 
tuned[36]. Schematic diagram of the band structure of Cu2O is shown in Figure 
1-16 for direct electron transition from the valence band to conduction band at 
the -point of the Brillouin zone[85-90].  
 
Figure 1-16: Energy band structure of Cu2O at the -point of the Brillouin zone. 
Reprinted with permission from ref[36].  
 
At 4.2 K, band to band transition energy for yellow, green, blue and indigo 
exciton series is 2.17 eV, 2.304 eV, 2.624 eV and 2.755 eV[36, 90]. Cu2O 
nanoparticles were used as a photocatalyst to split the water into H2 and O2 
using visible light irradiation[83]. Cu2O also show anti angiogenic activities 
which could be useful for cancer incubation[91]. Cu2O nanoparticles have been 
also used for light scattering imaging and as a probe for confirmation of 
proteins (Figure 1-17)[92]. 
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Figure 1-17: Dark-field light scattering image and light scattering spectra of 
Cu2O nanoparticles. Reprinted with permission from ref[92]. 
Most of the studies on Cu2O nanoparticles were to improve solar cell efficiency 
or photocatalytic activities but there was no systematic study is reported to use 
these nanoparticles for fluorescence biological imaging applications and also a 
systemic study of the optical properties of individual isolated Cu2O nanoparticles 
has not been reported in the past.    
 
1.8 Motivation for this research 
Although organic dyes, and a diverse range of additional nanomaterials, have 
been widely used for biological imaging, one of the major disadvantages of 
using fluorescent probes is that they often require high laser power excitation 
for bright emission so that they can be easily distinguishable from the auto 
fluorescence of a biological sample. However, the use of high laser power 
during fluorescence imaging is responsible for weakening the emission 
properties of the organic materials and as a result, they completely lose their 
emission properties within a very short time.  Laser based bioimaging is a widely 
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used tool in biology and requires fluorescence probes to emit light with low 
power excitation. Low power excitation is a very important requirement for bio 
imaging as high laser power not only diminishes optical properties of the organic 
dyes but also produces heat and coagulates protein of the biological sample 
that is used for the imaging[46]. Using a fluorescent nanomaterial which has a 
strong emission intensity with low excitation power only can enable long term 
biological imaging studies. There is also growing interest in synthesising such 
functional inorganic nanomaterials where they use semiconductor-
semiconductors, metal-semiconductor and metal-metal core shell 
nanomaterials to control their optical and electronic properties[93-102]. So, 
using a suitable nanomaterial as a fluorescent probe can be an alternative to 
commercially available fluorophores for biological imaging applications. 
Therefore, the first major objective of the thesis is to obtain Cu2O nanocubes 
with uniform size and high yield, the latter primary objective attribute is to 
explore the use of these Cu2O nanocube materials for bio imaging applications.  
Previously, there have not been many studies undertaken to investigate the 
fluorescent properties of uniform-sizes Cu2O nanocubes in relation to their 
suitability for bio imaging applications. Subsequently, the origin for their strong 
NIR emission, brightness, photostability at the single particle level has not been 
studied in the context of fluorescence imaging. Therefore, this present study 
aims to study the afore-mentioned optical properties, single particle emission, 
photostability, lifetime and brightness of these Cu2O nanocubes and how it can 
be optimized towards better imaging agents.  
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The next objective is to combine the optical properties of these Cu2O 
nanoparticles with NIR absorbing gold nanorods in the form of hybrid materials 
and investigate how both materials synergistically improve the optical properties 
towards bio-imaging. The major challenge is to synthesize such kind of 
materials and study their optical properties.  
Finally, cytotoxicity studies of pure Cu2O nanocubes were undertaken to 
explore the cytotoxicity of this nanoparticle in a biological system. Cell viability 
of these nanomaterials was carried out and it was observed that the cell viability 
was not significantly influenced by nanoparticle incubation regardless of time or 
nanoparticle concentration for HEK293 cells.  In addition, these cells did not 
exhibit any significant concentration-dependent increase in cytotoxicity at any 
time point. 
In summary, through exploring the applications of Cu2O nanomaterials for 
biological imaging applications, the four overarching aims of this thesis are:   
(1) Synthesise highly uniform Cu2O nanocubes, which emit in the NIR-I 
region, 
(2)  Investigate the optical properties and to explore the use of these 
materials as highly efficient labelling agents with high brightness, reduce 
blinking and photostable emission, 
(3) Develop hybrid materials that possess two different optical properties 
and study these materials’ suitability as imaging agents with the same afore-
mentioned attributes, 
(4) Investigate their cytotoxicity and show the potential of these materials as 
label free bioimaging agents. 
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1.9 Thesis outline  
This thesis has been structured as follows: 
Chapter 1: Introduction 
This chapter provides an overview of fluorescence probes and their application 
in bio imaging and outlines the layout of the thesis.  
Chapter 2: Synthesis of Copper(I) oxide (Cu2O) nanocubes 
This chapter presents the synthetic methodologies to obtain Cu2O nanocubes 
with uniform size and high yield using the seed mediated approach. Controlling 
the ageing time of the seeds and the concentration of the precursors was the 
two key parameters controlled during the synthesis to obtain the nanoparticles 
of uniform size and shape desirable for biological applications 
Chapter 3: Optical properties of single and ensemble of Copper(I) oxide 
(Cu2O) nanocubes 
This chapter describes the fluorescent properties of uniform-sized Cu2O 
nanocubes and includes a study of the temperature dependence on emission 
wavelength and brightness of ensembles and fluorescent properties of single 
particles. The estimated fluorescence lifetime of individual Cu2O nanocubes 
was also presented in this study. 
Chapter 4: In vitro biological imaging using Copper(I) oxide (Cu2O) 
nanocubes and their concentration-based cytotoxicity 
This chapter presents the application of the Cu2O nanocubes for bio-imaging 
applications as well as their cytotoxicity studies towards HEK293 cells and BV2 
cells. The comparison of fluorescence intensity between autofluorescence from 
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biological samples and Cu2O nanocubes and photostability of Cu2O nanocubes 
compared to other commonly used fluorescent probes is also presented in this 
chapter. 
Chapter 5: Au(rods)@Cu2O  metal/semiconductor hybrid nanostructures: 
Fluorescence enhancement through plasmon-exciton interactions for 
bioimaging applications 
This chapter presents the synthesis of hybrid core-shell nanostructures consists 
of gold nanorods and Cu2O shell and their attractive optical properties.  The 
unique combination of fluorescent Cu2O nanomaterials and NIR absorbing 
plasmonic gold nanorods (AuNR) is explored to form Cu2O core-shell 
nanoparticles. This chapter also presents intensity differences between 
autofluorescence from biological samples and Cu2O nanocubes, and a 
photostability comparison among the different commercially available 
fluorescent probes. 
Chapter 6: Conclusions and Scope for future work 
This chapter provides an overall conclusion of the above studies and makes 
some recommendations for future research opportunities involving the use of 
Cu2O nanoparticles as intrinsically fluorescing probes. 
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 Synthesis of Copper(I) oxide (Cu2O) 
nanocubes 
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2.1 Introduction  
Copper(I) oxide (Cu2O) is a p-type semiconductor material and can be 
synthesised in different morphologies such as nanocubes, nanospheres, 
nanorods and nano octahedron with simple chemical methods and low 
preparation costs[37, 72, 75-79, 103-110]. These chemical methods involve the 
surfactant templated reduction of Cu(II) ions with excellent control over the 
morphology of the Cu2O nanoparticles. Cuprous oxide shows a high absorption 
coefficient at around 438 nm in bulk materials and has more than 10% energy 
conversion efficiency which makes this material a good candidate for various 
photoelectronic applications, such as photovoltaic cells and photo-
capacitors[103, 111-113]. Other areas of interest that are using Cu2O 
nanoparticles are in the field of biological imaging[92] and photocatalysis[72, 
77, 83, 106]. 
 
A range of protocols has been developed for the synthesis of morphology-
controlled Cu2O nanoparticles[114-120]. In general, Cu2O nanoparticles are 
synthesized by hydrolysis of the Cu(II) precursors into their hydroxides and 
reducing the resultant Cu(II) hydroxide into Cu(I) oxides using mild chemical 
reducing agents in the presence of surfactant[72]. Gou et. al demonstrated a 
synthesis process of Cu2O nanocubes wherein an aquatic solution of CuSO4 
was reduced by sodium ascorbate in the presence of a surfactant, CTAB and 
NaOH at a temperature of 55 °C[103]. Zhang group reported a method of 
preparing nearly monodispersed Cu2O nanospheres where they used 
polyvinylpyrrolidone (PVP) as a stabilizer and sodium borohydride (NaBH4), as 
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a reducing agent, to reduce cupric acetate (Cu(CH3COO)2·H2O) dissolved in 
dimethylformamide (DMF) containing ~0.3% water in a reaction temperature 
85-90 °C[78]. Kuo et. al developed a method of synthesising Cu2O of different 
shapes what they called systemic shape evolution[121]. They were able to 
synthesis Cu2O of the different shapes, such as truncated cube, cuboctahedra, 
truncated octahedra, and octahedra using CuCl2, sodium dodecyl sulfate 
(SDS), hydroxylamine (NH2OH· HCl) and NaOH where they simply varied the 
volume of hydroxylamine to get different shaped Cu2O nanoparticles[121]. 
Here, SDS and hydroxylamine play a critical role in directing the shape of the 
nanoparticles.  SDS attaches to the (111) facets and blocks the growth of the 
nanoparticle on that direction and hydroxylamine influences the growth towards 
the (100) direction. As a result, some intermediate structure forms depending 
on the ratio of these two chemical compounds which then develops various 
shapes of copper(I) oxide nanostructures through surface reconstruction[121].   
 
In this research, Cu2O nanocubes were synthesised building upon a seed-
mediated approach[72]. Briefly, the seed-mediated synthesis consists of 
preparing very small Cu2O nanoparticles, followed by the addition of these 
seeds to the growth medium containing the precursors and subsequent growth 
of the nanomaterials on the seeds as heterogeneous nucleation centres. The 
main reasons for further exploring this method were, it offered a wide size range, 
well-defined cubic structure, simple room enviromment synthesis which is 
difficult to find in other synthesis processes and they are single crystals, 
quantified by the selected area (electron) diffraction (SAED) analysis showing 
clear dot patterns related to the single crystals of Cu2O nanocubes[72]. 
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However, there are also some challenges of using this reported synthesis 
process. One of the challenges relates to the low yield and as this research 
project was aimed to use Cu2O nanocubes for biological imaging, the project 
requires a scalable synthesis process that can produce a high quantity of 
materials while the main reported synthesis procedure can only provide 
micrograms of materials. So that the attempts were made to increase the yield 
of these nanocubes to support further characterisation and tests that are 
described in the following chapters. Other challenges of the previously reported 
synthesis process include a lack of monodispersity in terms of morphology. 
Also, well-formed nanocubes are only possible to fabricate after an extended 
period of time. A detailed description of Cu2O nanocube synthesis to address 
these issues and their characterisation is stated in the following sections. 
 
2.2 Experimental 
2.2.1 Chemicals used for Cu2O synthesis 
Copper (II) sulphate (CuSO4), Sodium dodecyl sulphate or SDS (C12H25NaO4S), 
(+)-Sodium L- ascorbate or SA (C6H7NaO6) and Sodium hydroxide (NaOH) 
were used in the synthesis of Cu2O nanocubes. All chemicals were obtained 
from Sigma-Aldrich and used as received. The water used was double distilled 
de-ionized Milli-Q water 18.2 MΩ•cm.  
2.2.2 Synthesis of the Cu2O nanoparticle using the 
seed-mediated approach  
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The synthesis of Cu2O nanocubes in this section builds upon a previously 
reported seed-mediated growth[72], however, the procedure has been modified 
significantly to further optimize the production of these materials for bioimaging 
applications. In the seed-mediated growth, firstly the seeds of Cu2O are usually 
prepared and these seeds act as a template for the subsequent growth of the 
nanomaterials.  The focus here is to develop a large-scale synthesis technique 
of Cu2O nanocubes which possess uniform morphology using simple methods. 
Cu2O nanocubes were initially synthesised following the same procedure that 
has been previously reported and is referred to as the base method hereafter. 
The seeds need to be removed from the solution within a certain time interval 
and the time it stays in the solution is an ageing time[72]. The ageing time of 
the seeds plays a critical role in controlling the size and morphology during the 
seed-mediated synthesis of nanoparticles. The first modification involves 
varying the ageing time of the seeds used for the synthesis of Cu2O nanocubes 
and their role in fine-tuning the morphology uniformity. In this approach, the 
concentration of the reactant precursors and the volume of the reaction media 
were kept constant, while the ageing time of seeds was varied, which is referred 
to as seed ageing time modification hereafter. The second modification of the 
synthesis process involves varying volume and the final concentration of the 
reactants. This approach is referred to as concentration modification hereafter. 
Firstly, in the base method of preparing Cu2O nanocubes (Figure 2-1), aqueous 
solutions of CuSO4 (0.001 M), SDS (0.33 M), SA (0.2 M) and NaOH (1 M) were 
required and prepared as mentioned in the experimental section 3.2. 
Afterwards, 0.25 mL SA (0.2 M)  was added to the 10 mL aqueous solution 
containing 0.001 M CuSO4 and 0.33 M SDS and stirred for 5 seconds, then 0.5 
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mL of NaOH (1M) was added to this mixture subsequently. After adding 0.5 mL 
NaOH in that mixture, the mixture was stirred for another 5 seconds, which 
resulted in the formation of first cycle Cu2O seed particles.  
 
Figure 2-1: Synthesis method of Cu2O nanocubes that was used initially 
following the reported method. Nanocubes forms in each cycle after 2 hours of 
ageing. Firstly, in the 1st cycle, 10 mL mixture of 0.001 M CuSO4 and 0.33 M 
SDS was taken in a vial then 0.25 mL of 0.2 M SA was added and stirred for 5 
seconds Afterwards, 0.5 mL of 1M NaOH was added in that mixture and then 
stirred for 5 seconds which makes seed particles for 2nd cycle. From this seed 
particles, 1 mL of seed particles were transferred to 9 mL mixture of 0.001 M 
CuSO4 and 0.33 M SDS for 2nd cycle reaction and repeat the steps of the first 
cycle to make seed particles for the 3rd cycle. From the 3rd cycle to 6th cycle 
steps were repeated that was used in the 2nd cycle. From the 1st cycle to 5th 
cycle 1 mL of seed particles were taken within 10 seconds of the addition of 
NaOH, for next cycle and rest of the solution of all cycles were kept for ageing 
for 2 hours to get nanoparticles from each cycle. 
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From these seeds, 1 mL of seed particles were taken for the next cycle to obtain 
larger nanocubes and the rest of the seed particles were left at room 
temperature for ageing to get nanoparticles from this cycle. In the 2nd  cycle, 
these 1 mL seed particles obtained from the 1st cycle were added to the 9 mL 
aqueous solution mixture containing SDS and CuSO4, followed by the addition 
of 0.25 mL SA. This mixture was stirred for 5 seconds prior to the addition of 
0.5 mL NaOH. After stirring the mixture for another 5 seconds, 1 mL of seed 
particles from the 2nd cycle was used as seeds for the 3rd cycle. The same steps 
of adding SA and NaOH was followed for 3rd  to 6th cycle, that was mentioned 
for the 2nd cycle. From every cycle, 1 mL of seed particles were taken within 10 
seconds of the addition of NaOH, for next cycle and rest of the solution of all 
cycles were kept for ageing for 2 hours to get nanocubes. After 2 hours of 
ageing, nanocubes were centrifuged for 10 minutes and centrifugation repeated 
three times. The resultant pellet was redispersed in 1 mL of ethanol, which was 
characterized. Since the size of the nanocubes grows every cycle, nanocubes 
obtained after 1st and 2nd cycle were centrifuged at a maximum RCF of 2744 
×g, while nanocubes obtained from the 3rd to 6th cycle were centrifuged at a 
maximum RCF of 988 ×g.   
 
2.2.3 Synthesis of Cu2O nanoparticle varying ageing 
time (seed ageing time modification) 
In this modification (Figure 2-2) of the synthesis process, concentration and time 
interval to mix the reactants were kept the same as the base method, except 
the seed ageing time. Similar to before, 0.25 mL of SA (0.2M) SA and  0.5 mL 
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of NaOH (1M) were added successively in  5 seconds interval to the 10 mL 
aqueous solution containing 0.001 M CuSO4 and 0.33 M SDS.  This mixture 
was left one hour for ageing, prior to the transfer of these seeds for the next 
cycle. 
 
Figure 2-2: Synthesis method of Cu2O nanoparticle varying ageing time (Seed 
ageing time modification). In this synthesis method concentration of the 
reactants and their mixing steps were the same as base method except for 
ageing time for seeds that were used in each cycle and final ageing time in each 
cycle to get nanocubes. Here, instead of taking seeds within 10 seconds of the 
addition of NaOH, the solution was kept for ageing for 1 hour to allow enough 
time for the seeds for nucleation and surface reconstruction. After 1 hour, 1 mL 
seeds were taken for the next cycle and the rest of the solution was kept for 
another one hour to get nanocubes. 
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In the base method, the seeds were transferred to the next cycle immediately. 
In this case, ageing time was increased to grow larger seeds After 1 hour, 1 mL 
of seed particles were transferred to the next cycle and the rest of the mixture 
was left for ageing for 1 hour, which was aged 2 hours in the base method. In 
the 2nd cycle,  1 mL of seed particles from the 1st cycle was added to the 9 mL 
mixture of 0.001 M CuSO4 and 0.33 M SDS and stirred for 5 seconds. After 
that, 0.25 mL of 0.2 M SA was added to the mixture and stirred for 5 seconds 
and mix with 0.5 mL of 1 M of NaOH. After adding NaOH, the mixture was stirred 
for another 5 seconds and left for ageing for 1 hour to get seed particles for the 
3rd cycle. After 1 hour of ageing, 1 mL of seed particles were transferred for the 
next cycle and the rest of the mixture was left for ageing for another 1 hour to 
get Cu2O nanocubes. The same process that was used in the 2nd cycle was 
followed from the 3rd to the 6th cycle.  
In this synthesis process, the seed solution that used in each cycle was left 
ageing for 1 hour whereas, in the base method, seeds were used within 5 to 10 
seconds of the final reactant being added.  That was the key modification made 
to the synthesis process of the base method.   
The 1 hour ageing of the seed solution provides additional time for nucleation 
and results in the formation of seed particles with uniform morphology, which 
eventually forms uniform shaped nanocubes. These aged-nanocube seeds 
were used as seeds for the next cycle, that can produce larger Cu2O nanocubes 
as well as an improvement in their uniformity in size. Another modification in 
this approach, as compared to the base method, involved ageing the 
nanocubes solution obtained after each cycle for 1 hour instead of two hours. 
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After 1 hour of ageing, nanocubes were centrifuged at a maximum RCF of 988 
×g and the pellet containing nanocubes were redispersed in 1 mL of ethanol.  
2.2.4 Synthesis of Cu2O nanoparticle varying reactant 
volumes (Concentration modification) 
In the second modification volume of the reactants and the final concentration 
of the reactants was varied in order to study the effect of reactant volumes and 
their concentrations in the formation of Cu2O nanocubes. The main drawback 
of the seed-mediated growth base method, discussed in Section 3.2.3, was the 
poor yield of Cu2O nanocubes which was also time-intensive and had less 
control over the morphology and aggregation. This was the reason, the 
synthesis method was tailored to increase the yield of Cu2O nanocubes 
compared to the reported seed-mediated approach. Therefore, the 
concentration and the volume of the reactants were judiciously varied to obtain 
nanocubes in high concentration without compromising the morphology 
uniformity. A solution containing 1 mM of CuSO4 and 33 mM Sodium dodecyl 
sulphate (SDS) was prepared and 30 ml of the prepared mixture was transferred 
to a Schott bottle (1st cycle) followed by the addition of 750 µL of 0.2 M (+)-
Sodium L-ascorbate (Figure 2-3). The solution was vigorously stirred for 5 
seconds, followed by the addition of 1.5 mL of 1 M NaOH and stirred another 5 
seconds. Then, 20 mL of solution from the 1st cycle was transferred to another 
Schott bottle (2nd cycle) with 180 ml of the starting solution and kept in constant 
shaking for 10 seconds. After that, 5 mL of 0.2 M (+)-Sodium L- ascorbate was 
added to the bottle of the 2nd cycle and stirred for 5 seconds. Afterwards, 10 mL 
of 1 M NaOH was added to the bottle of the 2nd cycle and then stirred for 
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another 5 seconds. The mixture of the 2nd cycle was kept standing for one hour 
(Figure 2-3). The synthesised Cu2O nanocubes were centrifuged at a maximum 
RCF of 2744 ×g and the pellet was washed three times (for ten minutes) and 
dispersed in 10 ml of ethanol. 
 
 
Figure 2-3: Synthesis of Cu2O nanoparticle varying reactant volumes (Seed 
aging time modification). In here, the initial concentration of the reactants was 
the same, however, the volume of the reactants was different for which final 
concentration of the reactants also different. In the 1st cycle 30 mL mixture of 
0.001M CuSO4 and 0.33 M SDS was mixed with 750 µL of 0.2 M (+)-Sodium L-
ascorbate.  The solution was vigorously stirred for 5 seconds followed by the 
addition of 1.5 mL of 1 M NaOH and stirred another 5 seconds to get seeds for 
the 2nd cycle. In the 2nd cycle, 180 mL mixture of 0.001M CuSO4 and 0.33 M 
SDS was mixed with 20 mL seeds from the 1st cycle and shake for 10 seconds 
then 5 mL of 0.2 M (+)-Sodium L- ascorbate was added to this mixture and 
shake for 5 seconds. Afterwards, 10 mL of 1 M NaOH was added to this mixture 
and shake for another 5 seconds which is then kept for ageing for 1 hour to get 
Cu2O nanocubes.   
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2.3 Results and Discussion 
2.3.1 Synthesis of the Cu2O nanoparticle using seed-
mediated approach (base method)  
As mentioned earlier 3.2.3, a seed-mediated method was followed to synthesise 
Cu2O nanocubes[72]. After synthesis, TEM and SEM images of these 
nanoparticles were collected to confirm the formation of nanoparticles and to 
estimate the size of the nanoparticles. shows the TEM and SEM images of the 
nanoparticles obtained at each level. 
SEM and TEM images of the nanocubes obtained from the 1st cycle (Figure 2-4 
a-1 and a-2) showed that the large aggregates of nanocubes that makes the 
estimation of individual particle size difficult. Nanoparticles obtained from this 
1st cycle were observed to be semi-spherical in shape (Figure 2-4 a-1 and a-2), 
which remains the same even in the 2nd cycle (Figure 2-4  b-1 and b-2) and 3rd 
cycle (Figure 2-4 c-1 and c-2). However, in the 3rd cycle, the average size of 
nanoparticles was increased by 126 nm as compared to the 2nd cycle. Size of 
nanoparticles was increased in every cycle because of the 1 mL final solution 
that had been added from the previous cycle, worked as seed particles for the 
next cycle. After the addition of all the reagents in each cycle, fine particles are 
formed and then they get adsorbed on the seed particles to form larger 
nanocubes. In the 4th cycle, nanoparticles became cubic in shape; however, a 
large portion of these nanoparticles was with an irregular shape (Figure 2-4 d-
1 and d-2). In the 5th cycle (Figure 2-4  e-1 and e-2) and the 6th cycle (Figure 
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2-4 f-1 and f-2) of this base method, nanoparticles are 382 ± 49 nm and 509 ± 
70 nm in size and formed well-shaped nanocubes without deformities. 
 
Figure 2-4: a-1 to f-1 corresponds to TEM images and a-2 to f-2 corresponds to 
SEM images of Cu2O nanoparticles from 1st cycle to 6th cycle, respectively, after 
2 hours of ageing that was synthesised following base method. Scale 200 nm. 
TEM (a-1) and SEM (a-2) image of the 1st cycle showing large aggregation of 
the spherical nanoparticles. The shape remains similar which is spherical for 
the 2nd (b-1 and b-2) and 3rd cycle (c-1 and c-2), although in the 3rd cycle, the 
average size of nanoparticles was increased by 126 nm compared to the 2nd 
cycle. From the 2nd cycle to 5th cycle, 1 mL final solution obtained from the 
previous cycle which then works as seed particles for the next cycle. Particles 
that were formed after adding all the reagents, get adsorbed on the seed 
particles and gone through surface reconstruction which eventually makes 
larger particles in each cycle. In the 4th cycle, nanoparticles became more cubic 
in shape compared to previous cycles; however, a large portion of these 
nanoparticles possess an irregular shape (d-1 and d-2). In the 5th cycle (e-1 and 
e-2) and 6th cycle (f-1 and f-2), nanoparticles are 382 ± 49 nm and 509 ± 70 nm 
in size, respectively, and well-shaped nanocubes with a smooth surface.  
Although monodispersity in shape was achieved for the 5th and 6th cycle, these 
nanocubes are irregular in size, synthesis method involved so many steps and 
had a very low yield which made them less suitable for bioimaging purposes.  
  
Although well-shaped nanocubes with a smooth surface were achieved in the 
5th and the 6th cycle of this synthesis method, these nanoparticles were irregular 
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in size. As until the 4th cycle of this method, nanoparticles were with a large 
number of deformities; Again, after finishing each cycle, 1mL of nanoparticles 
was achieved. However, the concentration of the nanocubes obtained in a 1 mL 
final solution in the cycle was not adequate enough which was only of nanogram 
level. Powder X-Ray diffraction (XRD) patterns of the synthesised Cu2O 
nanocubes provide information about the crystalline phase of the Cu2O 
nanocubes, also their crystallite structure and crystallite size[122, 123].  
 
Figure 2-5: a) XRD and b) intensity ratio between (200) and (111) crystalline 
plain of 1st to 6th cycle of Cu2O nanocubes. Powder X-Ray diffraction was 
studied on synthesised Cu2O nanocubes to determine their crystallinity and also 
to study any changes in the crystalline structure of the Cu2O nanocubes as a 
function of morphology. 
 
This study was performed to know if any changes in the crystalline structure of 
the Cu2O nanocubes occurred as a function of morphology at each cycle. All 
the powder X-Ray diffraction patterns of the samples from all cycles prepared 
using this base method are shown in Figure 2-5.  The 2θ values observed 
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correspond very well to the (110), (111), (200), (211), (220), (311) and (222) 
planes of the face centred cubic phase of Cu2O nanocubes (JCPDF no. 78-
2076). Among the six cycles investigated, the ratio between 2θ peaks 
corresponds to (200) and (111) planes increases with the increasing cycle 
number due to an increase of intensity to the peak corresponds to (200) plane. 
This is probably due to the restricted growth of (111) plane and growth of (200) 
planes, which may be the result of blocking of (111) plane by the surfactant 
[124] as it was reported that presence SDS and SO42- in the growth solution 
stabilises the (111) facets of Cu2O nanocubes[70, 71]. It should also be noted 
that high-energy surfaces are stabilised by the aggregation of seed particles 
and fine particles while low energy surfaces are stabilised by the surfactants 
[70, 72]. The appearance of (110) facet indicates intermediate stability between 
(100) and (111) facets[71]. Again, The peak width of (111) plane was found to 
be smaller as the number of cycles increased. This is probably due to the 
increase in the crystallite size[123]. To further confirm the formation of Cu2O, 
chemical state analysis of these materials was carried out using X-ray 
photoelectron spectroscopy (XPS) study of these materials. The XPS survey 
spectrum is shown in Figure 2-6 showed the presence of C1s, O1s, Cu2p, and 
Na1s core levels, which is a clear indication of the presence of these elements 
in the Cu2O nanocubes. The presence of C1s is attributed to the presence of 
the surfactant SDS on the nanocube surface. While the presence of Na is 
related to the use of sodium ascorbate and sodium hydroxide during the 
synthesis of nanocubes. Figure 2-6 b showed that the Cu 2p core level spectra, 
wherein in the spin-orbit components Cu 2p3/2 and Cu 2p1/2 exhibit their peak 
binding energies at 932.5 eV and 952.4 eV, correspond to the oxidation state of 
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Cu(I)[77]. Satellite peaks in CuO tend to be more intense than the satellite peaks 
present Cu2O structures. Also, the position of these satellite peaks is different 
in these two oxidation states. 
 
Figure 2-6 a)  XPS survey spectra of Cu2O nanocubes showing the presence 
of C, O, Cu and Na. b) XPS Cu2p scan showing Cu 2p 3/2 peak at 932.5 eV 
and Cu 2p ½  peak at 952.4 eV with satellite peaks at 943.8 and 946.3 eV 
representing the formation of Cu2O with small amounts of the CuO impurities 
based on the satellite peaks at 944.3 and 963.1 eV. 
 
The satellite peaks appearing at 943.8 eV and 946.3 eV are related to Cu(I) 
while the presence of the peaks at 944.3 eV and 963.1 eV relate to the existence 
of trace CuO impurities[125]. The XRD and XPS results indicate that the 
synthesised cubic structures are predominantly Cu2O structures. Other than the 
XRD and XPS analysis, the zeta potential of the particles obtained after both 
modification was also measured yielding -17.4 ± 4.7 mV.  
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The zeta potential information is valuable for future functionalizing of the 
nanocubes with additional materials for targeted biological imaging applications. 
This result also means that these Cu2O nanocubes can increase the surface 
adsorption ability between nanocubes and charged molecules for biolabelling 
application[126]. UV-Visible absorbance spectra of Cu2O nanocubes obtained 
after each cycle were collected and shown in Figure 2-7. The nanocube seeds 
obtained from the 1st cycle exhibit its absorption maxima around 350 nm, as 
shown in Figure 2-7 a. The absorption maxima for the nanocubes obtained after 
2 hours ageing in the 2nd cycle was at around 487 nm, this is may be due to the 
size of the nanoparticles was less than 100 nm which was 62.7 ± 14 nm. As it 
was reported that, relatively smaller nanocubes which have a diameter less than 
100 nm shows absorbance at around 490 nm, which is in close agreement with 
previous reports[72]. In the case of nanocubes obtained from the 3rd cycle, the 
UV-visible spectrum shows an absorption maximum centered around 490 nm 
and a NIR absorbance tail.  
The absorption maxima observed around 485 nm in the case of nanocubes 
obtained from the 3rd cycle, was red-shifted to 533 nm in the case of nanocubes 
obtained after the 5th cycle and a NIR absorbance tail also was appeared in this 
cycle (Figure 2-7). This is due to the size of the nanoparticles obtained from the 
3rd and 5th cycle is larger than 200 nm which is 188 ± 22 nm and 382 ± 50 nm, 
respectively, as larger nanocubes with above 200 nm diameter shows 
absorbance at 515-525 nm which also shows an additional absorbance feature 
that is NIR absorbance due to light scattering[72].  The result suggested that 
the absorbance of this Cu2O nanocubes is size dependent and the shifts in the 
absorbance peaks are due to the increase in the size of the nanocubes. Most 
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of the characterisation on the Cu2O nanoparticles was done on nanoparticles 
that were synthesised following the base method to confirm the formation of 
Cu2O materials. After confirmation of Cu2O formation, modifications on the 
synthesis process of the base method was made to get uniformity in morphology 
and to increase the concentration of nanocubes in resulting solution.  
 
Figure 2-7: a to d corresponds to UV-visible spectra of the Cu2O nanocubes 
from the final solution of 1st , 2nd , 3rd and 5th cycle, respectively,  after 2 hours 
of ageing. The UV-visible absorbance spectra from the final solution of the 1st 
cycle where the absorbance peak at around 351 nm (a). The absorbance peak 
from of the solution of the 2nd cycle was at around 487 nm (b), whereas from 
the 3rd cycle, absorbance was visible in two different places which are at 485 
nm and at NIR region (c). In the 5th cycle, the absorbance peaks at around 533 
nm which also shows a NIR tail (d).   
 44 
 
2.3.2 Synthesis of Cu2O nanoparticle varying ageing 
time (seed ageing time modification) 
The Cu2O nanocubes that were prepared using seed ageing time modification 
of the synthesis process were also examined under SEM and TEM (Figure 2-8)  
and Figure 2-9) to get a clear idea on any changes in the morphology of the 
Cu2O nanocubes due to this modification.  
In the first modification, after mixing all the reagents in the 1st cycle, the solution 
was left for ageing for 1 hour and the resultant particles were used as seed 
particles for the 2nd cycle. This one-hour ageing was sufficiently a longer time 
to ensure complete nucleation as compared to the 5 second ageing period to 
synthesis seeds that were used in the base method. During synthesis, an 
aquatic solution of CuSO4 forms Cu(OH)42- which then reduced by sodium 
ascorbate in the presence of SDS, starts nucleation and seed particles 
formation[72]. This 1 hour seed ageing time helps to improve the uniformity in 
the shape of Cu2O nanocubes due to the formation of uniform shaped nuclei in 
this method.  Seeds were kept for 1 hour for ageing in each cycle and after 
adding all the reagents, this final solution was kept another one hour for ageing 
to get well-shaped nanocubes. TEM images of these nanoparticles obtained 
from the 3rd to 6th cycle were taken and shown in Figure 2-8. According to TEM 
images, nanocubes synthesized following this method were highly 
monodispersed in morphology and comparatively smaller in size compare to 
nanocubes from the same cycle synthesised using the base method.  Figure 
2-9  shows the comparison of shape and size dispersity of Cu2O nanocubes 
from 4th cycle synthesised using two different methods where reagent 
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concentrations are the same but ageing time for seeds for these two methods 
is different.  
 
Figure 2-8: a to d corresponds to TEM images of the 3rd cycle to the 6th cycle of 
Cu2O nanocubes synthesised following modification 1. TEM images show that 
nanocubes that were highly monodispersed in morphology had been achieved 
due to this modification in the synthesis process of the base method, seeds 
were kept for ageing for 1 hour in each cycle. Here, improvement of the quality 
of nanocubes that were from the 3rd cycle to 6th cycle was emphasised, as, in 
the base method, 1st and 2nd cycle only produce aggregated spherical 
nanoparticles. Scale 200 nm.  
 
Figure 2-9 shows SEM images of Cu2O nanocubes, synthesised in the 4th cycle 
of the base method (Figure 2-9 a) and seed ageing time modification (Figure 
2-9 b), respectively. Here, the 4th cycle of the base method and seed ageing 
time modification are shown as an example to compare these two methods. As 
in the base method, seeds were taken instantly for each cycle so that they did 
not get enough time to form properly and shows some deformities, while for 
seed ageing time modification, seed particles were kept ageing for one hour to 
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allow them to be well-formed so that when they adsorbed fine particles on their 
surface, forming well-formed nanocubes. Cu2O nanocubes that are synthesised 
using the seed ageing time modification method are highly uniform in 
morphology (Figure 2-9 b) compared to the base method (Figure 2-9 a). 
 
Figure 2-9: a) and b) SEM images of Cu2O nanocubes, synthesised in the 4th 
cycle of the base method and seed ageing time modification, respectively to 
show the effect of seed ageing time modification. Scale 200 nm. 
 
Nanocubes synthesised following seed ageing time modification were highly 
monodispersed in morphology compared to the nanocubes synthesised 
following the base method. Despite the fact that there was a significant 
improvement in achieving uniformity in the morphology of Cu2O nanocubes 
following this synthesis method, this method was also as time-consuming as 
the base method 
2.3.3 Synthesis of Cu2O nanoparticle varying reactant 
volumes (Concentration modification) 
To increase the concentration of the nanocubes in the resultant solution, the 
second modification was made in the synthesis process where concentration, 
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volume and the ageing time of the reaction mixture were modified (Figure 2-3).  
In this case, 30 mL aqueous solution of CuSO4 and SDS, 0.75 mL of SA and 
1.5 mL of NaOH was used in the 1st cycle. In the base method, 10 mL aqueous 
solution containing CuSO4 and SDS, 0.25 mL of SA and 0.5 mL of NaOH that 
was used instead.   
 
Figure 2-10: Comparison of shape and size dispersity of Cu2O nanocubes from 
2nd cycle synthesised using two different methods where reagent volumes are 
different for these two methods. a) and b) SEM images of Cu2O nanocubes 
synthesised in the 2nd cycle of the base method and seed ageing time 
modification, respectively. As seed ageing time modification is up to 2nd cycle, 
in this figure, the 2nd cycle of the base method and seed ageing time 
modification are shown as an example to compare these two methods. In the 
base method, 10 mL mixture of 0.001 M CuSO4 and 0.33 M SDS was used in 
the 1st cycle and 9 mL mixture of 0.001 M CuSO4 and 0.33 M SDS was used in 
rest of the cycles. However, in seed ageing time modification, 30 mL mixture of 
0.001M CuSO4 and 0.33 M SDS was used in the 1st cycle and 180 mL mixture 
of 0.001M CuSO4 and 0.33 M SDS was used in the 2nd cycle. Again, in base 
method 0.25 mL of 0.2 M SA and 0.5 mL of 1M NaOH in all cycles whereas, in 
seed ageing time modification, 750 µL of 0.2 M (+)-Sodium L-ascorbate and 1.5 
mL of 1 M NaOH was used in 1st cycle and 5 mL of 0.2 M (+)-Sodium L- 
ascorbate and 10 mL of 1 M NaOH was used in the 2nd cycle. In the base 
method, 1 mL of seed was used from the 2nd cycle to the 6th cycle whereas, in 
seed ageing time modification, 20 mL of seeds was used for the 2nd cycle.   This 
modification only involves 2 steps and allows for the production of nanoparticles 
with high yield. Scale 200 nm. 
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In the 2nd cycle of this method, 180 mL mixture of CuSO4 and SDS, 5 mL of SA 
and 10 mL of NaOH to get around 200 mL of nanocubes which is 20 times larger 
in volume than previously mentioned methods. Nanocubes obtained from the 
resultant solution were in milligram level where as nanocubes obtained from 
base method were nanogram to micro gram level. This method is less time 
involved as it takes only two cycles to obtain the nanocubes with high yield and 
good uniformity in morphology. Figure 2-10 shows the SEM images of the 
nanocubes obtained from the base method and modified method which referred 
here as concentration modification. Nanoparticles obtained after the 2nd cycle 
of the base method (Figure 2-10  a) are spherical in shape and mostly 
aggregated whereas nanoparticles obtained after the 2nd cycle of the 
concentration modification (Figure 2-10  b) method was cubic in shape and has 
good uniformity in shape and size. 
2.4 Conclusion 
In summary, the seed-mediated approach of making Cu2O was modified to 
obtain Cu2O nanocubes with uniform morphology as well as in large quantities. 
In order to use these Cu2O nanocubes for bioimaging applications, it is a 
desirable requirement to develop a synthetic method that can produce Cu2O 
cubes with uniform morphology with high yield. Therefore, two major 
modifications were explored building upon the previously reported seed-
mediated growth method to achieve the desired monodispersity with high yield. 
In the first approach, the nanocubes morphology was made uniform by 
increasing the ageing time of the Cu2O seeds. In the second approach, Cu2O 
nanocubes synthesized in high yield without compromising the monodispersity, 
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wherein the reactant volume and their concentration increased to obtain high 
yields. Excellent control in the yield and size of Cu2O nanocubes without the 
need of any additional chemical has been achieved and the parameters that 
play a key role in controlling the yield and morphology have been investigated. 
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 Optical properties of single and 
ensemble of copper(I) oxide (Cu2O) nanocubes  
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3.1 Introduction  
Copper(I) oxide (Cu2O) is a p-type semiconductor material with a direct 
bandgap 2.17 eV in bulk form[36, 75-84]. This semiconducting material 
has attracted much attention due to its exceptional properties which are 
possible in nano-sized particles[36, 80-84]. For example, A film of Cu2O 
nanocubes able to provide a photocurrent density of ∼80 mA m−2 at a 
biased voltage 3 V using sunlight (100 mW cm−2)[112]. Qi et al. have 
used Cu2O nanoparticles for light scattering imaging of living cells and as 
a probe for confirmation of proteins[92], where they report changes in 
circular dichroism of specific proteins such as prion (PrPC) and bovine 
serum albumin (BSA) due to the introduction of Cu2O nanoparticles. 
Recently cuprous oxide found to regulate vascular endothelial growth 
factor (VEGFR2)[91].  Cuprous oxide nanoparticles can use as an 
antiangiogenic agent for the incubation of cancer, arthritis, diabetic 
retinopathy and pulmonary hypertension[91]. Not only on the bulk but also 
facet dependent electrical properties have also been studied from single 
Au@Cu2O core-shell nanoparticles where (111) facet showed very high 
conductivity compared to (100) facet[127]. This Cu2O nanoparticle has 
photocatalysis, catalysis and electrical properties which also has the 
potential to act as a fluorescent probe and nanomedicine. 
The emerging area of biophotonics requires the development of 
intrinsically bright and photostable luminescent nanoprobes. The 
approach followed in this work is to explore the optical properties of 
individual and isolated cubic Cu2O nanoparticles using low power 
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excitation because most of the characterisation and analytical studies that 
have been reported are on colloids or bulk materials which give a 
cumulative measurement[52, 128]. The light source from a single system 
plays a key role in some applications, for instance, measurement of 
absolute fluorescence and nonradiative recombination rates[128]. These 
kinds of studies require information from a single system where tiny 
fluctuation in the local environment may significantly affect the result.  In 
this study low power excitation was given preference, as collecting bright 
and stable emission from fluorescent organic dyes or nanoparticles using low 
laser excitation is essential when these fluorophores are used for biological 
imaging. Biological samples are sophisticated and highly responsive to laser 
irradiation as high laser power coagulates proteins of tissues, thus it can destroy 
a sample[46]. Hence, it is desirable for a fluorescent nanoparticle to exhibit 
bright emission, above that of any surrounding background fluorescence, 
with minimal optical excitation. In this research, individual Cu2O 
nanocubes were examined using silicon wafers which have been milled 
using a focused ion beam to create registration markers[129]. The marked 
substrates are visible in both a confocal microscope and scanning 
electron microscope (SEM) and enable the characterisation of isolated 
nanocubes without interaction from adjacent particles. It is the first study 
of the optical fluorescent properties of individual Cu2O nanocubes focusing 
on the intrinsic brightness and photostability of the material for bioimaging 
applications. In addition to studying the optical fluorescent properties of 
individual Cu2O nanocubes, temperature dependent optical properties and 
lifetime of ensemble Cu2O nanocubes also have been reported in this chapter.  
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3.2 Experimental 
3.2.1 Cu2O nanoparticle synthesis  
A seed-mediated growth method[75] was used to synthesise Cu2O nanocubes 
which were tailored to increase the yield of Cu2O nanocubes compared to the 
in the published synthesis process. Please see previous chapter (chapter 2) for 
details. 
3.2.2 Characterisation 
Initially, the morphological studies of synthesised Cu2O nanocubes were carried 
out with FEI Verios 460L scanning electron microscope using 10 kV and 0.8 nA. 
The structural characteristics of the synthesised materials were studied using 
the Bruker D8 Discover microdiffraction system which has a general area 
detector diffraction system and the Cu-Kα radiation source. The oxidation state 
studies of the prepared samples were studied using Thermo K-Alpha X-Ray 
Photoelectron Spectroscopic instrument at a pressure better than ̴10-8 Torr. The 
core binding energies of the elements were aligned at 285 eV for adventitious 
C1s core level energy. Si substrates were marked using focused ion beam 
milling with an FEI Scios FIB-SEM.  Each marked area on the silicon has a size 
of 286 µm × 286 µm with an etched depth of 1m. A beam current 3 nA at 30 
KV was used for 516 seconds with tilt 52° to mill each substrate. Fluorescence 
confocal images were taken using a 6 ps pulsed Fianium SuperChrome laser 
source, at a repetition rate of 40 MHz, with a centre wavelength of 520 nm or 
532 nm and a full width at half maximum (FWHM) of 10 nm. The optical imaging 
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was performed using a 532 nm dichroic mirror, 532 nm long pass filter, 532 nm 
short pass filter and a 100X 0.9 NA objective lens. 
 
3.2.3 Tracking individual particles 
Individual Cu2O nanocubes were studied using a marked silicon substrate[129] 
which was milled with a focused ion beam (FIB) (Figure 3-1).  
 
Figure 3-1: Si substrates were marked using focused ion beam milling with an 
FEI Scios FIB-SEM with an etched depth of 1m. A beam current 3 nA at 30 
KV was used for 516 seconds with tilt 52° to mill each substrate. 
 
The marked Si substrate was drop cast with one drop of the sample. A low 
magnification SEM image of the deposited, marked substrate was taken to 
locate regions of isolated particles. Afterwards, the individual particles were 
numbered (P1 to P19) and then optical data were collected for individual and 
isolated Cu2O particles. 
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3.3 Results  
Cu2O nanocubes were synthesised following concentration modification 
as described in the previous chapter (chapter 3). Scanning Electron 
Microscopic imaging of the Cu2O particles were carried out to confirm the 
uniformity in size and shape of the particles and Figure 3-2  shows the 
SEM image and the particle size histogram. SEM images confirmed the 
truncated cubic shape and smooth surfaces of the particle, an example 
image is shown in (Figure 3-2 a). Based on the SEM images, the average 
lengths of cubic Cu2O are 293 ± 18 nm along one side (Figure 3-2  b). 
 
Figure 3-2: a) SEM image of Cu2O nanocubes showing cubic morphology with 
an isolated individual nanocube shown in the inset. b) Size distribution Cu2O 
nanocubes based on the SEM images. 
 
The optical absorption spectrum of synthesized Cu2O nanocubes in water 
was collected and are given in Figure 3-3.  These particles exhibit a 
characteristic absorption band centred around 481 nm (Figure 3-3). In 
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addition to this absorption band, there is another absorption band in the 
near-IR region at 750 nm, which is in agreement with previously reported 
literatures[75, 77].  
 
Figure 3-3: UV-visible absorbance spectrum of Cu2O nanocubes in water. 
 
3.3.1 Temperature dependent brightness and emission 
from ensemble Cu2O nanocubes  
It is important to identify the specific excitation wavelength, which is responsible 
to obtain very high emission intensity from Cu2O nanocubes at the NIR region. 
Therefore, to understand the effect of excitation wavelength, a dried sample of 
Cu2O nanocubes on a Si wafer were excited using 400 nm to 600 nm 
(FWMH=10) pulsed laser with 80.00 MHz repetition rate using 11 W at room 
temperature (21°C) (Figure 3-4).   
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Figure 3-4 a-e) Emission spectra data of ensemble Cu2O nanocubes collected 
using 400 nm to 600 nm pulsed laser excitation with 11 W laser power at room 
temperature to determine the region of the excitation wavelength that gives best 
emission intensity. According to this study, the highest emission intensity is 
observable between 450 nm to 550 nm excitation wavelength. Data was taken 
using a dried sample on a Si wafer. 
 
The result shows a peak in the emission at around 780 nm for all the excitation 
wavelengths. Figure 3-4  (a-e) shows the obtained emission spectrum collected 
at different excitation wavelengths (400 nm, 450 nm, 500 nm, 550 nm, 600 nm) 
with the same laser power. However, the highest emission intensity was 
observable, when the nanocubes were excited between 450 nm to 550 nm 
excitations. In particular, excitation at 550 nm gave the strongest emission band 
around 800 nm. Due to this result, the rest of the studies were performed in 
between 450 nm to 550 nm excitation wavelength region. The emission 
observed around 800 nm is attributed to oxygen vacancies within Cu2O 
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nanocubes[36, 130] and defect sites, which was dependant on the temperature. 
Therefore, after identifying the range of excitation wavelength of the material 
that gives highest emission intensity, the effect of temperature on the 
photoluminescence emission properties of Cu2O nanocubes and photostability 
was taken over a range from 7 K to 300 K (Figure 3-5) using a pulsed laser with 
532 nm excitation wavelength with only 2 µW excitation power.  
 
Figure 3-5: a) Emission spectral data of Cu2O nanocubes from temperature 7 K 
to 300 K. using a pulsed laser (Repetition rate= 80.00 MHz) with 532 nm 
excitation wavelength and only 2 µW excitation power.  
When Cu2O nanocubes were excited at 7 K, the spectra showed strong 
emission band centred around 721 nm. As the temperature was increased to 
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50 K, this causes the emission band a few nanometer redshifts. At 150 K and 
300 K, the photoluminescence spectra collected from Cu2O nanocube shows a 
peak at 743 nm and 819 nm, respectively, which is 22 nm peak shift for 150 K 
and 98 nm peak shift for 300 K compared to the peak wavelength obtained at 7 
K temperature. This trend of a gradual shift of peak wavelength was observed 
for every 50 K increase in temperature up to 300 K. This result suggests that 
spectral tuning for Cu2O nanocubes are possible by tuning temperature using 
same experimental condition. 
To further understand the shift in the peak as a function of temperature, the 
photoluminescence spectra from Cu2O nanocubes were fitted with the 
Gaussian fit and the results are presented in Figure 3-6. After the fitting using 
Gaussian, at 7 K the spectra show a major peak (peak no. 2) at 721 nm which 
is due to doubly charged oxygen vacancies (𝑉𝑂
2+)[36, 130]. Other than the peak 
at 721 nm, there was one minor peak observed at 789 nm. According to the 
previous reports, peak at 810 nm was assigned to singly charged oxygen 
vacancies (𝑉𝑂
1+)[130]. The peaks at 634 nm, 661 nm and 669 nm for the 
emission spectra at 7 K also has been seen but they are not included in the 
fitting as the position of these peaks are in a small distance, including those 
peaks was making the fitting inaccurate. It was also reported that an additional 
peak can be seen at 610 nm at 4.2 K due to 1s ortho-exciton via an electric 
quadrupole transition[36] and a peak at 760 nm is also observable due to some 
fractions of a metastable CuxOy defect phase, although the exact position of the 
peaks and their relative intensities highly depend on the way materials was 
synthesised as well as sample processing methods[36]. At 50 K the major peak 
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has shifted to 724 nm, 1st minor peak (peak no. 1) was seen at 663 nm and 2nd 
minor peak (peak no. 3) shifted to 772 nm which becomes relatively narrower 
at this temperature. At 150 K, major peak (peak no. 2) shifted to 743 nm, 1st 
minor peak (peak no. 1) disappeared and 2nd minor peak (peak no. 3) shifted to 
810 nm which matches with peak position observed for singly charged oxygen 
vacancies (𝑉𝑂
1+) of copper (I) oxide[130].  
 
Figure 3-6 Gaussian fitted photoluminescence emission spectra of Cu2O 
nanocubes as a function of temperature. Emission spectra that were taken at 
50 K to 300 K were fitted in here. The peaks at 634 nm, 661 nm and 669 nm for 
the emission spectra at 7 K is not included in the fitting because these three 
peaks in a small distance make the fit inaccurate. Here peaks are numbered as 
1, 2 and 3. 
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At every 50 K temperature increase, intensity differences between the major 
peak (peak no. 2) and the 2nd minor peak (peak no. 3) has reduced and 2nd 
minor peak became narrower with every 50 K temperature increase.  The 2nd 
minor peak (peak no. 3) becomes the major peak at 819 nm at a temperature 
of 250 K which then transitions to become the only peak at a temperature of 
300 K with the same peak position while the rest of the peaks disappeared. In 
addition to the emission wavelength, the photostability of the nanoparticles 
during the excitation is a vital factor, especially for bioimaging applications. 
Photostability data of Cu2O nanocubes were collected from 7 K to 300 K using 
532 nm excitation wavelength with 2 µW average power (with FWHM = 10 nm 
and 80.00MHz repetition rate) for 20 minutes, as shown in Figure 3-7.  
 
Figure 3-7: Photostability of an ensemble of Cu2O nanocubes from 7K to 300 K 
using 532 nm excitation wavelength with 2 µW average power for 20 minutes.  
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Emission counts ranged between 161k and 355k counts/s with only 2 µW 
excitation power and remained relatively stable for a period of at least 20 
minutes, indicating highly photostable characteristics of the Cu2O nanocubes. 
It should be mentioned that the laser power used in this part of the research is 
considerably lower than that used for many biological imaging applications [25]. 
For example, Goetz, M., et al. reported confocal imaging during mini-
laparoscopy where they used 715 W average laser power with maximum 
power limited to 2000 W[26]. Laser power ranged between 300 mW and 600 
mW was used for histomorphologic imaging of brain tumours in vivo [27].   
In addition to the photo stability, the brightness of the nanoparticles during the 
excitation is another key factor for bioimaging applications. Brightness (or 
emission intensity) data of Cu2O nanocubes were collected from 7 K to 300 K 
using 532 nm excitation wavelength with 2 µW average power (with FWHM = 
10 nm) for 20 minutes, as shown in Figure 3-7. In addition, the relationship 
between excitation power and emission counts was studied for ensemble Cu2O 
nanocubes under 7 different temperatures (Figure 3-8). This study shows that 
it is possible to increase fluorescence intensity from 161k counts/s and 355k 
counts/s from ensemble Cu2O nanocubes using only 2 µW of excitation power 
with a pulsed laser. The intensity of emitted light was observed to increase with 
decreasing temperature. This result shows that the fluorescence emission 
intensity of the Cu2O nanocubes can be increased by decreasing temperature 
without changing the excitation power. This result also shows that Cu2O 
nanocubes could be useful for the bio imaging of cryopreserved samples. 
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Figure 3-8 Initial emission counts of an ensemble of Cu2O nanocubes from 7K 
to 300 K using 532 nm excitation wavelength with 2 µW average power. 
 
3.3.2. Fluorescence brightness and photostability of 
individual Cu2O nanocubes 
One of the major objectives of this chapter is the study of the fluorescent 
properties of individual nanoparticles. Therefore, the individual and 
isolated Cu2O nanocubes were studied using a template registration 
marker on a silicon substrate.  A template registration marker, shown in 
Figure 3-9 a-1  was milled into a silicon substrate with a focused ion beam 
to enable the characterization of isolated Cu2O nanocubes Figure 3-9 b-1. 
This was followed by drop casting the synthesised nanocubes and drying 
under air. A low magnification scanning electron microscope (SEM) image 
was taken to locate regions of individual and isolated Cu2O nanocubes 
(Figure 3-9 a-2)[129]. The marked silicon platform was used to locate and 
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measure the optical properties of individual particles under a confocal 
microscope.  
 
Figure 3-9: a-1) Template of the registration marker which was milled on a 
silicon substrate using a focused ion beam (FIB) (b-1). SEM image of Cu2O 
nanocubes dropped cast on a silicon substrate with registration markers to 
enable the location of the exact area of a certain isolated Cu2O nanocube. a¬-
2) Low magnification SEM image of Cu2O nanocubes. This type of image was 
taken of different areas of the substrate to select individual nanocubes P1 to 
p19. a-3) High-resolution SEM image of the boxed region in (a-2) which was 
taken after acquiring the optical data to avoid the effect of the electron beam on 
the optical properties of the Cu2O nanocubes. Particles P6 and P7 are shown 
as an example of two isolated nanocubes. b-2) Confocal fluorescence image of 
the same field-of-view as in (a-2). b-3) High-resolution confocal fluorescence 
image of the boxed region in (b-2) of particles P6 and P7. 
 
To confirm the size, morphology, and isolation of particles, high-
magnification SEM images were taken after all optical data were acquired 
from 19 individual nanocubes in order to minimise any effect of possible 
electron beam damage on their optical properties. Figure 3-9 a-1 
represents the template of the registration pattern which has been milled 
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as shown in. As an example, a high magnification SEM image of two 
typical individual nanocubes (particles number P6 and P7) is shown in 
Figure 3-9 a-3. Confocal fluorescence images for low and high 
magnifications are shown in Figure 3-9 b-2 and Figure 3-9 b-3, respectively. 
These images were collected using the same field-of-view as the SEM 
images shown in Figure 3-9 a-2 and Figure 3-9 a-3, respectively, to enable 
subsequent photo stability and spectral measurements.  
Fluorescence spectral data was collected from individual and isolated 
Cu2O particles on the marked silicon substrate using 520 nm (2.38 eV) 
supercontinuum pulsed laser with 11 µW average excitation power with 
80.00 MHz repetition rate (1.7 W/cm2) at room temperature with an FWHM 
= 10 nm.  Figure 3-10 a shows the fluorescent spectra of the individual 
nanoparticles. The 520 nm wavelength excitation was chosen because 
the highest emission intensity is possible to get in between 450 nm to 550 
nm according to our previous finding stated in this chapter. Under these 
excitation conditions, the emission peak of individual Cu2O nanocubes 
was centred around 754.6 ± 2nm (Figure 3-10 a and Figure 3-10 b) which 
can be assigned to doubly charged oxygen vacancies (Vo)[131] in the 
Cu2O nanocube lattice. Having an emission at 754 nm makes this material 
a promissing candidate for biological imaging as tissue absorption and 
autofluorescence are minimal in this emission range[132]. The peak in the 
distribution of full width at half-maximum (FWHM) emission is around 85 
nm (Figure 3-10  c).  
 
 66 
 
 
Figure 3-10: a) Fluorescence emission spectra of 19 individual Cu2O 
nanocubes excited at 520 nm with a supercontinuum picosecond pulsed laser. 
b) Emission peak wavelength distribution. The emission peak centered at 754.6 
± 2 nm which can be correlated to oxygen vacancy (Vo). This wavelength is well 
suited for biological imaging applications. c) The peak in the distribution of full 
width at half-maximum (FWHM) emission is around 85 nm.  
 
In addition to the emission wavelength, brightness and photostability are 
crucial factors for bioimaging applications. Brightness and photostability 
data were collected from the same isolated individual Cu2O particles 
(using 520 nm excitation wavelength with 11 µW average power with 
FWHM = 10 nm for 120 seconds), as shown in Figure 3-11 a. Emission 
counts ranged between 226k and 780k counts/s and remained stable for 
a period of at least 120 seconds, indicating photostable characteristics of 
the Cu2O nanocubes. It should be mentioned that the laser power used in 
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this part of the research is considerably lower than that used for some 
biological imaging applications[133].  
In addition, the relationship between excitation power and emission 
counts was studied for 6 individual Cu2O particles using 5 excitation 
powers (Figure 3-11  b). This study shows that it is possible to observe 
counts ranging between 76k counts/s and 130k counts/s from a single 
Cu2O nanocube using only 2 µW of excitation power with a pulsed laser. 
The intensity of emitted light was observed to increase with increasing 
excitation power (Figure 3-11 b). It is an important factor in bioimaging to 
use low power excitation lasers as there are reports indicating that higher 
laser power can damage biological samples[46].  
 
Figure 3-11: a) Fluorescence intensity of the same nanocubes as in over a 120 
second time period of continuous excitation with 11 μW time-averaged power 
at the sample from the supercontinuum pulsed laser. Emission intensities of 
these individual particles ranged between 226k to 780k counts/s. b) The 
fluorescence emission intensity of 6 selected individual Cu2O nanocubes under 
2 μW, 5 μW, 11 μW, 15 μW and 20 μW excitation power. The selected 
nanocubes in (b) are a subset, chosen for no particular reason, of those studied 
in (a).  This result indicates that individual Cu2O nanocubes have the ability to 
produce considerably bright emission while using low excitation powers. 
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The results showed that when a pulsed laser is used for imaging, 
saturation has not occurred over a range up to 20 µW laser excitation 
power. The intensity of the emission from individual Cu2O with 20 µW 
laser excitation was ranged between 470k counts/s and 602k counts/s. In 
order to evaluate the fluorescence intensity at higher excitation power, 
power of the laser and power density over a specific area was increased 
and the intensities were estimated and given in Figure 3-12.  
 
 
Figure 3-12: Fluorescence intensity of the selected nanocubes plotted against 
the increasing laser power and power density using a pulsed laser (a and b) 
and CW (Continuous-wave) laser (c and d) with 532 nm excitation wavelength. 
Here, individual nanoparticles are numbered as P13-P19. 
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At the higher excitation powers, the intensities of the emission showed a 
non-linear increase for both of the laser sources and the rate of the 
increase in the emission counts decreases as shown in Figure 3-12 a and 
b for individual nanocubes. The Cu2O nanocubes showed no saturation 
up to 207 µW average excitation power or 3.16E5 W/cm2 excitation power 
density for pulsed laser that clearly demonstrates the emission of these 
nanocubes remains stable even with high laser excitation (Figure 3-12 a 
and b) whereas, in case of CW (Continuous-wave) laser source, emission 
intensity increases up to 77 µW or 1.12E5 W/cm2 laser excitation for all 
three individual nanocubes (Figure 3-12 c and d) which then dropped at 
127 µW or 1.85E5 W/cm2 laser excitation. Emission intensity started 
increasing again from 207 µW or 3.01E5 W/cm2 excitation power for CW 
laser source which then start saturating from 407 µW or 5.93 E5 W/cm2 
excitation power (Figure 3-12 c and d). It is to note that there is a large 
difference in case of emission intensity between these two excitation 
power sources. For example, with 77 µW excitation power emission 
intensity from two individual nanocubes using pulsed laser was more than 
1M from each (Figure 3-12 a) whereas with same excitation power 
emission intensity using CW laser was nearly half compared to the pulsed 
laser which ranges from 520k to 675k (Figure 3-12 b). In semiconductors, 
photoluminescence is the consequences of the recombination of photo-
induced charge carriers[134]. When this material excited with light energy, 
negatively charged electrons from valence band transferred to the 
conduction band and simultaneously create positively charged holes in 
valance band. Since these excited electrons are very unstable, they come 
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back to the valance band and recombine with holes. During this process, 
a certain amount of energy gets released which then transform into heat 
or light energy[134]. The higher emission intensity in case of use of pulsed 
laser may be due to excited electrons from the nanocubes having enough 
time to come to the valance band from the excited state and recombine 
with holes to release light energy between pulses.  On the other hand, in 
case of CW laser, excited electrons from the nanocubes might not get 
enough time to come to the valance band as it is a continuous excitation 
and recombine with fewer holes, as a result, releases less light energy 
compared to the pulsed laser sources.  
 
3.3.3. Fluorescence lifetime 
The fluorescence lifetime of a fluorophore is a fundamental physical 
parameter for fluorescence lifetime-based imaging and sensing, which 
provides important information about the photophysics of the fluorophore 
[135]. Fluorescence lifetime has a range of applications such as tissue 
lifetime imaging, brain tissue analysis, blood pathologies, eye pathologies, 
dental pathologies and, drug delivery and release[135]. Fluorescence 
lifetime-based imaging focusing on NAD(P)H autofluorescence can 
distinguish cancer from noncancerous tissue[136]. Differentiating 
between healthy and atherosclerotic arterial walls is possible using 
fluorescence lifetimes of endogenous fluorophores of those blood 
vessels[137, 138]. According to previous reports, a range of fluorescence 
lifetime sensitive fluorophores, organic dyes, fluorescent proteins and 
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quantum dots have been used for biological imaging[135]. Therefore, 
lifetime measurements of these Cu2O nanocubes are important prior to its 
use in bioimaging applications and Figure 3-13  shows the lifetime 
measurements. In this present work, fluorescence lifetime has been 
studied using the same 11 individual Cu2O nanocubes, (Figure 3-13 a).  
 
Figure 3-13: Fluorescence lifetime measurements of 11 individual nanocubes 
(a) and their lifetime distribution (b and c). Faster component of the fluorescence 
lifetime ranges from 0.185 ns to 0.193 ns (b) and the slower component ranges 
from 4.9 ns to 5.7 ns (b). 
 
After excitation with 520 nm pulsed laser, there were two components 
found of fluorescence lifetime. Among the two components of 
fluorescence lifetime, one of them is a faster component which ranges 
from 0.185 ns to 0.193 ns (Figure 3-13 b) and the other one is a slower 
component which ranges from 4.9 ns to 5.7 ns (Figure 3-13 c).  
After excitation, an electron leaves valence band and enters to the 
conduction band and creates electron-hole pairs which are called exciton. 
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According to multi exciton theory[139-141], radiative decay from quantum 
dots created by several excitonic states (mono-, bi-, triexcitonic, etc) 
where the short lifetime component creates from the decays of the tri- and 
biexcitons whereas, the long lifetime component originates from the 
emission of the exciton[135]. Similar to the quantum dots, Cu2O 
nanocubes are semiconductors and based on this theory, the faster 
component of the lifetime of Cu2O may be due to the decay of tri- and 
biexcitons and long lifetime component could be originated from the 
emission of the excitons[135]. Fluorescence lifetime-based biological 
imaging could also be a possible application for Cu2O nanocubes. 
  
3.4. Conclusion 
In conclusion, the optical properties of ensemble and individual Cu2O 
nanocubes were investigated. Ensembles of Cu2O nanocubes were excited 
with different excitation wavelengths from 400 nm to 600 nm and the result 
shows a peak in the emission at around 780 nm for all the excitation 
wavelengths but highest was observable when the nanocubes were excited 
between 450 nm to 550 nm excitation wavelengths. This strong emission at NIR 
I region tends to blue shift at lower temperatures, hence their emission 
wavelength and intensity can be tuned as a function of temperature. Oxygen 
vacancies and their defect structures were found to be responsible for their 
emission in the NIR region.  Individual Cu2O nanocubes were studied using a 
marked substrate which was milled with a focused ion beam to locate and 
collect optical data from 19 individual particles. This study reveals that single 
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Cu2O nanocube can emit light with counts up to 487K counts/s for at least 120 
seconds with only 11 µW (1.7 W/cm2) laser excitation. Highly bright and 
photostable intrinsic fluorescence from Cu2O nanocubes at low excitation 
powers suggests that the nanocubes are suitable for long time bioimaging 
experiments. Lifetime measurements of individual nanocubes were estimated 
and found to have two component life times. Overall, Cu2O nanocubes were 
demonstrated to have a NIR emission, high brightness and photostability, which 
enable these materials as desirable candidates for bioimaging applications.  
 74 
 
 In vitro biological imaging using 
Copper(I) oxide (Cu2O) nanocubes and their 
concentration-based cytotoxicity   
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4.1 Introduction 
The field of nanoscience and nanotechnology has introduced a range of 
nanomaterial and varied their physical, chemical and biological properties 
through modifying their size, shape, composition and morphology to make them 
suitable for therapeutics[142-151], imaging and diagnosis[152-156] 
applications. Nanoparticles are also commonly used for drug delivery, 
biosensing and biological imaging. In some cases, these biomedical 
applications also required a deliberate injection of nanoparticles into the 
body[157]. For this reason, it is critical to know the cytotoxicity of those 
nanoparticles before introducing them into the body for biomedical applications 
such as imaging and drug delivery.  
There are several assays available to study the cytotoxicity of these 
nanomaterials such as neutral red assay, Trypan blue assay, lactate 
dehydrogenase (LDH) assay and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide assay, and the majority of these tests involve 
measuring cell death via colourimetric methods[157]. Neutral red is a eurhodin 
dye that can cross the plasma membrane through diffusion and then 
accumulate into the lysosomes of the cells[158]. However, non-viable or 
damaged cells cannot take up the dye[157, 159]. Cytotoxicity can be quantified 
using a fluorescent plate reader. Unlike the neutral red assay, Trypan blue 
stains dead cells and stain them blue whereas live cells remain colourless[157]. 
Incase of LDH assay[160], a red formazan formed after treating the cells with 
assay which gives absorbance at 490 nm. The number of cell damage is 
determined with this assay. Another widely used cytotoxicity assay is MTT[161], 
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3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide a produces 
formazan product within the living cells. It is a cell viability assay similar to the 
neutral red assay.   
It is also important to know whether the fluorescence probes are easily 
detectable when it is introduced to the biological sample for successful 
biological imaging[37]. Proteins, antigens, nucleic acids and other molecules 
are usually labelled with fluorescent probes which give them a tremendous 
sensitivity during imaging under fluorescence microscope[20]. For example, 
particular antigens can be detected through fluorescently tagged antibodies 
using fluorescent microscope which might not be possible if the antibody was 
unlabelled[20]. However, as most of the commercially available organic 
fluorophores bleach within a few seconds to a few minutes and give limited time 
for fluorescence imaging, the photostability of a fluorescence probe plays an 
important role for biological imaging as it enables long term repeated imaging 
and complex image acquisition[37, 52].  
In chapter 2, it was demonstrated that the synthesis of uniform sized Cu2O 
nanocubes was performed. This was followed by studying the optical properties 
of individual and ensemble of Cu2O nanocubes, as discussed in chapter 3. In 
particular, the observed brightness, photostability and suitable lifetime of these 
Cu2O nanocubes enable these materials as potential candidates for bio-imaging 
applications without the requirement for additional fluorescence labels. In this 
research, cytotoxicity of Cu2O nanocubes was studied on two cell lines, HEK 
293 (Human embryonic kidney cells 293) and BV-2 cells (BV-2 microglial cells) 
using Neutral Red assay and Lactate dehydrogenase (LDH) assay to know the 
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suitable concentration of Cu2O nanocubes for bioimaging applications. Other 
than cytotoxicity study, photostability and fluorescence intensity of the Cu2O 
nanocubes was studied after introducing these nanoparticles in mouse 
cumulus-oocyte complex. A detail description of concentration-based 
cytotoxicity of Cu2O nanocubes and in vitro biological imaging with Cu2O 
nanocubes are given below.  
4.2 Experimental 
4.2.1 Chemicals used for cumulus-oocyte complex 
preparation for biological imaging   
The chemicals used for the imaging study are αMEM supplemented with bovine 
serum albumin (BSA; ICPbio, Glenfield, New Zealand), Recombinant human 
follicle-stimulating hormone (50 mIU/ml; Organon, Oss, The Netherlands) and 
equine chorionic gonadotropin (eCG; Folligon, Intervet, Boxmeer, The 
Netherlands). 
4.2.2 Chemicals and the cell lines used for cytotoxicity 
study with neutral red uptake assay 
Chemicals and the cell lines used for cytotoxicity study with neutral red uptake 
assay are HEK 293 and BV2 cell lines, Neutral red (3-amino-7-dimethylamino-
2-methyl-phenazine hydrochloride)  (Sigma), Dulbecco’s formulation PBS 
tablets (Bio-Whittaker), Trypsin–EDTA (0.05% wt/vol trypsin, 0.02% wt/vol 
EDTA) (BioWhittaker), Eagle’s minimum essential medium (EMEM)) 
 78 
 
(BioWhittaker), Fetal Bovine Serum, qualified, heat inactivated (GIBCO); 200 
mM L-GIn (BioWhittaker); 50 mgL-1 gentamycin sulphate (BioWhittaker); 2 mgL-
1 Fungizone (BioWhittaker); nonessential aminoacids (BioWhittaker), Glacial 
acetic acid (Sigma), Ethanol 96% (Sigma), 0.4% (wt/vol) Trypan blue solution 
(Sigma) and 5% Glutaraldehyde of the commercial 25% (Sigma). 
4.2.3 Chemicals and the cell lines used for cytotoxicity 
study with LDH cytotoxicity assay 
Chemicals and the cell lines used for cytotoxicity study with LDH cytotoxicity 
assay are HEK 293 and BV2 cell lines, Pierce LDH Cytotoxicity Assay Kit 
contains substrate mix, lyophilizate and 0.6mL assay buffer which was stored 
at -20°C with proper protection from light. This assay kit also contains 2.5mL10X 
lysis buffer, 12mL stop solution and 6μL LDH Positive control which was stored 
at 4°C.  
4.2.4 Methodology  
4.2.4.1 Incubation condition and sample preparation for 
cytotoxicity study 
Cells were incubated with varying concentrations (0 ng/ml – 4 µg/ml) of Cu2O 
for either 2 h, 24 h, or a 2 h incubation followed by removal of nanoparticles and 
22 h of regular cell culture. A total of 2.5 × 104 HEK293 cells and 1.5 × 104 BV2 
cells were seeded onto 96-well cell culture plates and were incubated overnight 
to ensure attachment prior to the administration of nanoparticles. All 
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experiments were performed in triplicates and a total of N=3 experiments were 
completed for this study.  
 
4.2.4.2 Cell viability/cytotoxicity study using Neutral 
Red assay: 
Cell viability was measured using a Neutral Red assay according to published 
protocols[158]. Briefly, after the conclusion of incubations with nanoparticles, 
the cell media is aspirated and replaced with a Neutral Red dye-containing 
media. Neutral red dye is accumulated within viable cells. After a 2 h incubation 
with the dye, cells were washed briefly with phosphate buffered saline, and the 
dye is leached out of the viable cells using a solution containing 46% ethanol 
and 1% glacial acetic acid. The fluorescence level of the solution in each well 
(excitation: 530 nm emission: 645 nm) was measured using a fluorescent plate 
reader. A higher fluorescence level indicates increased cell viability. 
4.2.4.3 Cytotoxicity study using Lactate dehydrogenase 
(LDH) assay: 
To make the reaction mixture of LDH assay, one vial of substrate mix, 
lyophilizate was dissolved in 11.4 mL Milli-Q water which was mixed gently until 
it was fully dissolved. One vial of assay buffer was thawed to room temperature 
and then was mixed with 11.4 mL substrate buffer. This sample mixture was 
protected from light until use. Lactate dehydrogenase (LDH) activity in the cell 
supernatant after incubation with Cu2O nanoparticles was measured according 
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to the manufacturer’s protocol (Thermo Fisher 88953). As mentioned earlier, 
LDH is an essential enzyme present in the intracellular environment. As a result 
of cytotoxic damage or cell membrane disruption, LDH is released from the cells 
into the extracellular space. An increase in LDH activity in the cell supernatant 
is therefore indicative of cellular damage and cytotoxicity[160]. Since this only 
happens when the cell membrane is damaged, the presence of this enzyme in 
the culture medium is been considered as dead cell marker and the relative 
amounts of live and dead cells within the medium can then be quantitated by 
measuring the amount of released LDH using a colorimetric or fluorometric LDH 
cytotoxicity assay.   
4.2.4.4 Sample preparation for mouse cumulus-oocyte 
complex (COC)  imaging  
All animal work was approved by the University of Adelaide Animal Ethics 
Committee.  Female mice were administered 5 IU equine chorionic 
gonadotropin (i.p.) (eCG; Folligon, Intervet, Boxmeer, The Netherlands). 46 
hours post-eCG injection, ovaries were collected and blastocyst and cumulus-
oocyte complex (COC) liberated from antral follicles. COCs were then placed in 
maturation medium and matured for 16 hours in a volume of 50 μl medium/COC 
at 37°C under paraffin oil, in humidified air comprised of 20% O2, 6% CO2 and 
N2 balance. Following maturation, COCs were fixed in 4% paraformaldehyde in 
phosphate-buffered saline (PBS) and mounted on glass slides using DAKO 
Fluorescence Mounting Medium (Dako, NSW, Australia). Cu2O nanocubes 
were transferred to water and were drop cast on the biological sample to study 
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the Fluorescence emission intensity variation between fixed biological sample 
and Cu2O nanocubes.  
4.3 Results and discussion 
4.3.1 Cytotoxicity of Cu2O nanocubes 
The purpose of the cytotoxicity study is to assess the effects of Cu2O 
administration on two different cell types and to characterise the concentration 
and time dependency of these effects. To determine cytotoxicity two different 
assays such as Neutral red assay and LDH assay was used.  
Cytotoxicity of Cu2O nanocubes on HEK cells using Neutral red assay and 
LDH assay 
HEK293 cells are human embryonic kidney derived cells, a very common cell 
line used in cellular biology in-part due to the ease of genetic manipulations. 
This means that they are normally used to study intracellular pathways by either 
over or under expressing select proteins in the pathway. They are not 
phagocytic, and therefore serve as a control for passive uptake of 
nanoparticles[162]. Neutral red assay and LDH assay was used to determine 
concentration-based cytotoxicity of Cu2O nanocubes. Seven different 
concentrations (62.5 ng, 125 ng, 250 ng, 500 ng, 1 µg, 2 µg and 4 µg) of Cu2O 
nanocubes and one blank were used for cytotoxicity test. After introduction of 
Cu2O nanocubes, cells were incubated with Cu2O nanocubes for either for 2 
hours and 24 hours period or for a 2-hour period followed by a removal of 
nanoparticles and 22 hours of regular cell culture. Afterwards either neutral red 
assay or LDH assay was introduced for the cytotoxicity test.  Figure 4-1 shows 
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the HEK cell viability as a function of Cu2O nanocubes concentration.  As 
mentioned earlier, the neutral red test is a cell viability test and according to the 
fluorescence data from this study, cell viability of HEK cells was not significantly 
influenced by nanoparticle incubation regardless of time, nanoparticle 
concentration (R2= 0.03, p = 0.29). Additionally, no significant difference was 
observed in any of these individual effects (p>0.05) (Figure 4-1).  
 
Figure 4-1: Cell viability of HEK cell lines after incubating them using seven 
different concentrations (62.5 ng/mL, 125 ng/mL, 250 ng/mL, 500 ng/mL, 1 
µg/mL, 2 µg/mL and 4 µg/mL) of Cu2O nanocubes and one vehicle control (0 
ng/mL of Cu2O) for 2 hours to 24 hours period. The result shows HEK cells were 
not significantly influenced by nanoparticle incubation regardless of incubation 
time and nanoparticle concentration. 
 
HEK cell type did not exhibit any significant concentration-dependent increase 
in cytotoxicity at any time point (p>0.05) compared to vehicle control (0 ng/mL 
of Cu2O, Figure 4-2) with LDH assay as well. This is clearly shown in Figure 4-2  
that depicts the HEK cell viability as a function of Cu2O nanocubes 
concentration, estimated by LDH cytotoxicity assay. In case of LDH assay[157, 
160], LDH released from damaged cells catalyses lactate to pyruvate through 
reduction of NAD+ (Nicotinamide Adenine Dinucleotide) to NADH (Nicotinamide 
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Adenine Dinucleotide Dehydrogenase) and promotes the reduction of 
tetrazolium salt (INT) to a red formazan which gives absorbance at 490 nm. The 
number of cell damage is proportional to the amount of LDH released.  
 
Figure 4-2: LDH activity of HEK cell lines after incubating them using seven 
different concentrations (62.5 ng/mL, 125 ng/mL, 250 ng/mL, 500 ng/mL, 1 
µg/mL, 2 µg/mL and 4 µg/mL) of Cu2O nanocubes and one vehicle control (0 
ng/mL of Cu2O) for 2 hours to 24 hours period. The result also shows that HEK 
cells were not significantly influenced by nanoparticle incubation regardless of 
incubation time and nanoparticle concentration. 
 
This assay is known not to damage healthy cells, the assay can be performed 
directly in the cell culture wells containing a mixed population of viable and dead 
cells. Therefore, this assay can be used to determine the number of non-viable 
cells in a mixed population of healthy and damaged cells and may also be used 
to estimate the number of cells in a sample[160]. 
Cytotoxicity of Cu2O nanocubes on BV2 cells using Neutral red assay and 
LDH assay 
BV2 cells are an importal mouse microglial cell lines, which are the 
immunocompetent phagocytic (they are able to “eat” foreign matter and cellular 
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debris) cells in the central nervous system[163]. They are used in this study as 
a cell line which would readily take up surrounding nanoparticles. These cells 
were also incubated with the same seven different concentration of Cu2O 
nanocubes before treated with LDH assay and one vehicle control was kept for 
each of the cases. Figure 4-3 shows the effect of Cu2O nanocubes 
concentration on the BV2 cell viability, which was calculated using the LDH 
assay.  
 
Figure 4-3:  Cell viability of BV2 cell lines after incubating them using seven 
different concentrations (62.5 ng/mL, 125 ng/mL, 250 ng/mL, 500 ng/mL, 1 
µg/mL, 2 µg/mL and 4 µg/mL) of Cu2O nanocubes and one vehicle control (0 
ng/mL of Cu2O) for 2 hours to 24 hours period. The result shows similar to HEK 
cells, there was no significant influence was visible on BV2 cells due to the 
incubation with Cu2O nanocubes, regardless of incubation time and 
nanoparticle concentration. 
 
Similar to HEK 293 cells, BV2 cells also did not exhibit any significant 
concentration-based cytotoxicity regardless of incubation time and 
concentration of Cu2O nanocubes (Figure 4-3).  However, as mentioned earlier, 
to assess cellular damage, lactate dehydrogenase (LDH) activity in the cell 
supernatant after incubation with Cu2O nanoparticles was measured. Figure 4-4 
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shows the estimated LDH activity as a function of Cu2O nanocubes 
concentration. Nanoparticle incubation significantly altered the LDH activity 
measured in the cell supernatant (R2=0.44, p<0.0001) (Figure 4-4).  
 
Figure 4-4: LDH activity of BV2 cell lines after incubating them using seven 
different concentrations (62.5 ng/mL, 125 ng/mL, 250 ng/mL, 500 ng/mL, 1 
µg/mL, 2 µg/mL and 4 µg/mL) of Cu2O nanocubes and one vehicle control (0 
ng/mL of Cu2O) for 2 hours to 24 hours period. For BV2 cells, LDH activity has 
not elevated after 2 hours of incubations with Cu2O nanocubes regardless of 
the Cu2O concentration for BV2 cells. However, after 24 hours of incubation 
with Cu2O nanocubes for BV2 cells, for 4000 ng/mL and 2000 ng/mL LDH 
activity largely increased, although cells that are treated for 2 hours then 
washed and kept for 22 hours (2+22 hours incubation) for regular incubation 
showed much lower LDH activity for these two concentrations compared to 24 
hours incubations.  
 
Post-hoc analysis with Tukey’s correction for multiple comparisons[164] further 
revealed that that in BV2 cells, LDH activity was not significantly altered directly 
after 2 h incubations at any concentration (p > 0.05). However, a further 
incubation 22 hours of Cu2O resulted in a significant elevation in LDH activity 
after a 2-hour incubation of 4 µg/ml Cu2O (mean difference from vehicle 
incubation = 0.89, p<0.05). After a 24-hour incubation with Cu2O, BV2 cells 
exhibited significantly increased cytotoxicity in the 2 µg/ml (mean difference 
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from vehicle = 1.09, p<0.01) and 4 µg/ml (mean difference from vehicle = 1.49, 
p<0.0001) conditions. There were also significant elevations of LDH activity in 
2 µg/ml and 4000 ng/ml concentrations compared to 62.5 ng/ml, 125 ng/ml and 
250 ng/ml concentrations for a 24 hour incubation, while only 4000 ng/ml 
resulted in increased LDH compared to 500 ng/ml and 1000 ng/ml 
concentrations for 2+22-hour incubation, therefore indicating a concentration-
related increase in cell damage causing the release of LDH. of BV2 cells.  
Live cell imaging was performed using Differential interference contrast 
microscope (DIC) to observe uptake of Cu2O nanoparticles where cells were 
imaged continuously for 2 hours. In Figure 4-5, magnified images of live BV2 
cells at different time point shows the uptake of Cu2O nanoparticles by BV2 cell. 
 
Figure 4-5: Uptake of Cu2O nanoparticles by BV2 cells at different time point. 
Scale bar 10 µm. 
 Live cell imaging was performed using a DIC microscope to visualise combine 
effect of Cu2O nanoparticles concentration and phototoxicity during imaging on 
BV2 cells (Figure 4-6). 
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Figure 4-6: Live cell was imaged continuously imaged for 2 hours using a DIC 
microscope with or without Cu2O nanoparticles to show the combined effect cell 
imaging and Cu2O concentration. After 2 hours of imaging, cells with 4 µg/mL 
Cu2O shows more cell death then cells with 1 µg/mL Cu2O and control.
LDH activity was studied after 2 hours of continuous imaging which shows cells 
with 1 µg/mL Cu2O do not show elevation of LDH activity. However, cells with 4 
µg/mL Cu2O nanoparticles shows an increase of LDH activity compare to the 
control (Figure 4-7).  
 
Figure 4-7: LDH activity of BV2 cells after 2 hours of continuous imaging with 0 
µg/mL Cu2O (Control), 1 µg/mL Cu2O and 4 µg/mL Cu2O. 
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4.3.2. Biological imaging with Cu2O nanocubes 
Cu2O nanoparticles have been introduced to mouse embryo to compare 
the brightness of autofluorescence and Cu2O nanoparticles to know 
whether Cu2O nanocubes are easily distinguishable under a fluorescence 
microscope. The clear difference between the autofluorecence and 
fluorescence from Cu2O nanocubes are seen in Figure 4-8. Cu2O 
nanoparticles showed very bright fluorescence under simultaneous 
excitation with 405 nm and 473 nm compared to auto fluorescence. Cu2O 
nanocubes and autofluorescence from cumulus oocyte complex emit light 
at a different wavelength with the same excitation which makes the Cu2O 
nanoparticles easily detectable in a biological sample. 
 
Figure 4-8: Confocal fluorescence image of a mouse cumulus-oocyte complex 
with Cu2O nanocubes where red dots are Cu2O nanocubes. 
 
Photostability of Cu2O nanocubes (Figure 4-9 a-1, a-2 and a-3) and Cu2O 
nanocubes with mouse cumulus oocyte complex (Figure 4-9 b-1, b-2 and 
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b-3) were studied after 2 hours of continuous using Olympus commercial 
confocal microscope excited at 405 nm, 473 and 560 nm simultaneously. 
The images of the complex at different times are shown in Figure 4-9. This 
result suggests that Cu2O nanocubes remain highly photostable even 
after 2 hours of excitation and these nanocubes are easily distinguishable 
from the auto fluorescence of mouse cumulus oocyte complex.  
 
 
Figure 4-9: Photostability study of Cu2O nanocubes (blue dots) that was imaged 
continuously using Olympus commercial IX83 confocal microscope excited at 
405 nm, 473 and 560 nm simultaneously for 2 hours. 
 
Photostability of the Cu2O nanocubes is also remarkable compared to 
standard commercially available fluorescent probes. It has previously 
been reported that commercially available fluorescent probes such as 
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Alexa Fluor 647, polyacrylonitrile beads and carbon dots have a short 
bleaching time which limits their application for long term bioimaging 
studies during the course of an experiment[52]. Photostability of Cu2O 
was compared with photostability of Alexa 647, polyacrylonitrile beads, 
Au nanoclusters, carbon dots, nanodiamonds and nanorubies for two 
minutes [52]. Alexa 647 showed lowest photostability (2 %) followed by 
Au nanoclusters (24 %) and polyacrylonitrile beads (39 %). Figure 4-10 
shows the comparison of photostability of various semiconductor 
fluorescent materials.   
 
Figure 4-10: Comparison of the photostability of Cu2O nanocubes with 
commercial dyes and emerging fluorescent nanoparticles over a time period of 
120 seconds. The photostability of Cu2O nanocubes is 98% higher than the 
widely used commercial Alexa 647 dye and 48 % higher than carbon dots. 
Cu2O  nanocubes, nanorubies and nanodiamonds are showing 100% 
photostability over this time period.  
 
Photostability of Cu2O was the highest (100%) which is similar to 
nanodiamonds and nanorubies compared to the aforementioned 
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fluorescent probes (Figure 4-10). This comparison further highlights the 
potential this material has for long term biological imaging applications. A 
bioimaging demonstration of the intrinsically fluorescent Cu2O nanocubes 
was made through their use as fluorophores coupled with a mouse 
cumulus-oocyte complex. The Cu2O nanocubes were imaged with the 
same experimental conditions used for optical characterization of 
individual and isolated nanocubes as in Chapter 3.   
 
Figure 4-11 Confocal fluorescence image of a mouse cumulus-oocyte complex 
with Cu2O nanocubes. Bright dots are Cu2O nanocubes. b) Histogram showing 
the relative brightness of autofluorescence (blue bars) and Cu2O nanocube 
fluorescence (orange bars). The autofluorescence histogram shows the 
distribution of pixel intensities within the boxed region in (a). The Cu2O 
histogram shows the brightness distribution of 20 manually selected Cu2O 
particles in (a). The Cu2O nanocubes were observed to be approximately 4 
times brighter than autofluorescence from the mouse cumulus-oocyte complex 
hence making them easily distinguishable. 
 
The fluorescence emission of the Cu2O nanocubes was compared to the 
autofluorescence within the mouse cumulus-oocyte complex. The 
confocal image of the mouse cumulus-oocyte complex with 
Cu2Onanocubes drop-casted on the surface to study the difference 
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between auto fluorecence and Cu2O fluorecence. Figure 4-11 shows the 
confocal fluorecence image of the mouse cumulus-oocyte complex with 
Cu2O nanocubes, wherein, Cu2O nanocubes were observed as bright 
dots is shown in Figure 4-11 a. The bright dots on the surface of the mouse 
cumulus-oocyte complex correspond to the fluorescence emission from 
Cu2O nanocubes. The histogram in Figure 4-11 b shows the relative 
brightness of autofluorescence from the mouse cumulus-oocyte complex 
compared to Cu2O nanocube fluorescence. The autofluorescence 
histogram collected from the distribution of pixel intensities within the 
boxed region in Figure 4-11 a and the Cu2O histogram (Figure 4-11 b) 
shows the brightness distribution of 20 manually selected Cu2O particles 
in Figure 4b. Fluorescence from Cu2O was observed to be four times 
higher in intensity compared to the autofluorescence signal from the 
cumulus-oocyte complex which made them easily distinguishable (Figure 
4.8 a and b).  The attractive characteristics of Cu2O nanocubes, such as 
their long photostability and high brightness, highlight their potential as an 
alternative to commercially available fluorescent probes for bioimaging 
applications.  
 
4.4 Conclusion 
In conclusion, cell viability was not significantly influenced by nanoparticle 
incubation regardless of time, cell type or nanoparticle concentration for 
HEK293 cells and these cells did not exhibit any significant concentration-
dependent increase in cytotoxicity at any time point. For BV2 cells, LDH activity 
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has not elevated after 2 hours of incubations with Cu2O nanocubes regardless 
of the Cu2O concentration for BV2 cells. However, after 24 hours of incubation 
with Cu2O nanocubes for BV2 cells, for 4 µg/mL and 2 µg/mL LDH activity 
largely increased, although cells that are treated for 2 hours then washed and 
kept for 22 hours for regular incubation showed much lower LDH activity for 
these two concentrations compared to 24 hours incubations. This study 
suggests that concentration-based cytotoxicity highly depends on cell types. 
Live cell imaging was performed with a DIC microscope which shows cellular 
uptake of Cu2O nanoparticles and an increased LDH activity for BV2 cells with 
4 µg/mL Cu2O when it was imaged continuously for 2 hours. As cellular uptake 
of the Cu2O nanoparticle for BV2 cells only takes a few minutes, incubation time 
could be as small as 15 minutes for this cell type. For phagocytic cells, short-
term standard incubation such as for 2 hours incubation, nanoparticles 
concentration can be used as much as 4 µg/mL. In case of long-term incubation 
such as 24 hours incubation, the use of less than 500 ng/mL is suggested. 
According to this study, Cu2O nanocubes are bright which makes helps 
distinguishable them from autofluorecsence of biological samples.   They are 
highly photostable compared to the autofluorescence from a biological sample 
or other commercially available organic fluorophores that can be imaged 
continuously without photobleaching for at least 2 hours. 
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 Au(rods)@Cu2O  
metal-semiconductor hybrid nanostructures: 
Fluorescence enhancement through plasmon-
exciton interactions for bioimaging applications 
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5.1 Introduction  
In the previous chapters, the potential of Cu2O nanocubes for fluorescent-
based bio-imaging applications was discussed. In particular, the synthesis 
procedure for the controlled fabrication of Cu2O nanocubes, with emission 
from both single particles and ensembles, was discussed. However, the 
fluorescent properties of Cu2O nanocubes for bioimaging applications are 
not limited by their intrinsic optical properties, they can be extended by 
combining additional nanomaterials into composite structures.  
Metal nanoparticles are an interesting class of nanomaterials, which 
exhibit strong surface plasmon resonant (SPR) absorption in the visible 
region of the electromagnetic spectrum[165, 166]. For example, gold 
nanoparticles of different shapes exhibit one or two and sometimes even 
more SPR absorption bands.  Gold nanoparticles of different shapes 
including rods, cubes, triangles and prisms[167-169] are commonly used 
in diverse fields such as plasmonics[170-174], catalysis[175-184], 
sensing[185-192], bio-imaging[152-156], nanoelectronics [193-195] and 
biomedical fields[142-149, 196]. Among them, gold nanorods are an 
interesting class of materials, which have a transverse and longitudinal 
SPR (LSPR) absorption bands. The absorption region of the LSPR bands 
is controlled by the aspect ratio of the nanorods and as the aspect ratio 
increases, LSPR bands can be shifted to the near infrared region[197]. 
Therefore, combining gold nanorods and Cu2O into a single composite 
structure, the synergistic combination of these materials could lead to 
novel optical properties.  
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Several types of hybrid nanomaterials have been fabricated with gold 
nanoparticles such as Au@Cu2O core-shell nanoparticles, Au@ZnO 
hybrid pyramids, PbS@Au heterostructure, CdS@Au nanostructure and 
TiO2@gold nanoparticles[102, 198-205]. These hybrid nanomaterials 
were made mostly to modify the plasmonic properties of the metal 
nanoparticles or for photocatalytic activities of the semiconductor 
nanoparticles. In the case of Au@Cu2O core-shell nanoparticles, Cu2O 
shell formation on the surface of gold nanoparticles core was found to 
enhance and shift the SPR absorption band of gold nanoparticles[206]. 
Recently it has been reported that third harmonic generation from gold 
nanorods can be enhanced by making thin Cu2O shell on Au 
nanorods[205]. Although the synthesis of Au@Cu2O core-shell 
nanoparticles have been reported previously, changes in absorbance 
spectra during the formation of Cu2O shell on gold nanorods and the 
changes in fluorescence properties after the formation of Cu2O shell on 
the gold nanorods have not been studied. Comparison of the fluorescence 
properties of Au@Cu2O core-shell nanoparticles with other commercially 
available nanoparticles or with autofluorescence from biological samples 
also has not been reported to date. These areas of research which have 
not been previously studied will set the objectives of the work presented 
in this chapter.  Synthesis of Au@Cu2O hybrid materials, studying their 
optical properties and exploration of what additional advantages these 
hybrid materials have for bio-imaging applications will be discussed. 
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5.2 Experimental 
5.2.1 Chemicals for Au(rods)@Cu2O synthesis  
The synthesis procedure to form the Cu2O nanostructures is different from 
the synthesis procedure described in the previous chapter. An additional 
chemical, Hydroxylamine hydrochloride chloride (NH2OH· HCl) is added 
to this synthesis of the hybrid materials. Copper (II) chloride (CuCl2), 
Sodium dodecyl sulphate (C12H25NaO4S), Gold (Au) nanorods (0.035 
mg/mL) in deionised water with a capping agent CTAB, Sodium hydroxide 
(NaOH) and Hydroxylamine hydrochloride chloride (NH2OH· HCl) were 
used in the synthesis of Au(rods)@Cu2O hybrid nanostructure. All 
chemicals except Au nanorods were obtained from Sigma-Aldrich and 
used as received. Au nanorods were obtained from Nanopartz and the 
average length of this Au rods was 40 nm with 10 nm average diameter. 
The water used was double distilled de-ionized Milli-Q water 18.2 MΩ·cm. 
 
5.2.2 Chemicals used for the cumulus-oocyte complex 
preparation  
Chemicals used to prepare mouse cumulus-oocyte complex was αMEM, 
supplemented with bovine serum albumin (BSA; ICPbio, Glenfield, New 
Zealand), Recombinant human follicle-stimulating hormone (50 mIU/ml; 
Organon, Oss, The Netherlands) and equine chorionic gonadotropin 
(eCG; Folligon, Intervet, Boxmeer, The Netherlands). 
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5.2.3 Cumulus-oocyte complex preparation  
Mouse cumulus-oocyte complex (COC) samples were prepared to 
introduce the Au(rods)@Cu2O core/shell nanoparticles.  Au(rods)@Cu2O 
core/shell nanoparticles were transferred to water and were drop cast on 
the mouse COC sample to study the intensity variation between the 
autofluorescence from COC and the fluorescence from Au(rods)@Cu2O 
core/shell nanoparticles.  
 
5.2.4 Au(rods)@Cu2O hybrid nanostructure synthesis  
The Au(rods)@Cu2O hybrid nanostructures were synthesized using a 
method reported earlier with significant modification[121, 207].  The 
concentration of the gold nanorods used here was 0.21 mg/mL. At first, 
9.1 mL of water, 100 µL CuCl2 of 0.1 M and 0.087 g SDS were mixed 
together and this mixture was left for 3 minutes under sonication to obtain 
a clear solution. After that, 180 µL Au nanorods, 250 µL NaOH of 1M and 
450 µL NH2OH.HCl of 0.2 M was added step by step and stirred for 10 
second in each step, which then left for ageing for 2 hours. The 
synthesised Au(rods)@Cu2O nanocubes were centrifuged at a maximum 
RCF of 6700 ×g and washed three times for ten minutes each and 
redispersed in 5 ml Milli-Q water.     
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5.2.5 Characterization  
The morphological studies of synthesised Au(rods)@Cu2O  core/shell 
hybrid were carried out with FEI Verios 460L scanning electron 
microscope using 10 kV and 0.8 nA and JEOL 1010 transmission electron 
microscope using an accelerating voltage of 100 kV. Absorbance spectra 
were taken using a Cary 60 UV-vis (Agilent Technologies) 
spectrophotometer. EDS mapping was performed using an Oxford XMax-
80T EDS detector. Fluorescence confocal images were taken using a 6 
ps pulsed Fianium SuperChrome laser source, at a repetition rate of 40 
MHz, with a centre wavelength of 532 nm and a full width at half maximum 
(FWHM) of 10 nm. The imaging was performed using a 532 nm dichroic 
mirror, 532 nm long pass filter, 532 nm short pass filter and a 100X 0.9 
NA objective lens.  
 
5.3 Results and discussion 
As previously introduced, the Au nanorods that were used to form the 
core/shell nanoparticles were 40 nm in length and 10 nm diameter, which 
yields an aspect ratio 4 for these nanorods. Figure 0-1 (a) shows Au 
nanorods in deionised water with capping agent CTAB whereas Figure 0-1 
(b) shows the SEM image of Au nanorods (as received) deposited on a 
silicon substrate.  
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Figure 0-1: Au nanorods (0.035 mg/mL) in deionised water (a) and SEM image 
of Au nanorods on a silicon substrate (b). The average length of these Au rods 
is 40 nm with 10 nm average diameter. 
 
The addition of CuCl2 to the gold nanorods dispersion leads to the 
formation of a Cu2O shell around each of the nanorods. The addition of 
NH2OH.HCl and NaOH were then performed to initiate the hydrolysis of 
CuCl2 into Cu(OH)2 first, which was subsequently reduced into Cu2O by 
NH2OH.HCl. Alkaline pH favours the hydrolysis of CuCl2, while the 
hydroxylamine acts as a mild reducing agent that can reduce Cu(II) into 
Cu(I) species in the following reaction[121, 208]. 
2Cu(OH)4
2−+2NH2OH→Cu2O + N2+5H2O+4OH- [121] 
Gold nanorods were surface protected with CTAB surfactant, a cationic 
surfactant, which give a surface positive charge to the gold nanorods.  The 
zeta potential of the Au nanorods was found to +35 mV. These gold 
nanorods have an important role in the formation of the Cu2O shell 
formation by acting as a template for the hydrolysis of CuCl2 into Cu(OH)2 
which is then followed by the formation of Cu2O by mild reduction from 
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the as-formed Cu(OH)2.  Figure 0-2  a shows an image of the 
Au(rods)@Cu2O nanoparticles dispersion and the corresponding SEM 
images of these Au(rods)@Cu2O nanoparticles is shown in Figure 0-2 b.  
 
Figure 0-2: Au(rods)@Cu2O core/shell nanoparticles in deionised water(a). 
SEM (b and c) and TEM image (d) of Au(rods)@Cu2O core/shell nanoparticles 
on a silicon substrate. The average length of this Au(rods)@Cu2O core/shell 
nanoparticles is of 80.6±10 nm (e) with 25.6 ± 3.5 nm average shell thickness 
(f). 
 
High magnification SEM and TEM images of these hybrid nanoparticles 
were then performed to confirm the presence of the Cu2O shell formation. 
As shown in Figure 0-2 c and d respectively, it is the presence of gold 
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nanorods can be observed buried within a Cu2O shell. Since gold is a 
heavy element, this gives sufficient contrast even within the surrounding 
Cu2O shell. After the Cu2O shell has been formed around the Au 
nanorods, the length of the Au(rods)@Cu2O core/shell nanoparticles was 
increased to 80.6±10 nm, wherein the shell thickness was found to be 
25.6 ± 3.5 nm according to SEM and TEM images (Figure 0-2 e and f).  
To confirm the presence of Cu, O and Au in the Au(rods)@Cu2O 
core/shell nanoparticles, energy-dispersive X-ray spectroscopy (EDX) 
analysis of these materials were carried out and shown in Figure 0-3.  
 
Figure 0-3: Spectra of Au(rods)@Cu2O core/shell nanoparticles using energy-
dispersive X-ray spectroscopy showing the presence of Cu, O and Au in these 
nanoparticles. 
 
The presence of CuKα1, AuMα1 and O Kα1 lines in the EDX analysis 
clearly confirm the presence of these elements in the Au(rods)@Cu2O 
nanoparticles. Since the shell was made up of Cu2O, the CuKα1 and O 
Kα1 lines are more pronounced than the AuMα1 line in the 
Au(rods)@Cu2O nanoparticles 
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To further confirm the formation of the core-shell structure, UV-visible 
absorption spectra were taken during the formation of the shell, as shown 
in Figure 0-4. Absorption spectra of the formation of core-shell 
nanoparticles were followed kinetically after mixing the initial reactants 
such as an aqueous solution of CuCl2, SDS, Au nanorods and NaOH. 
After mixing the final reactants  UV-visible spectra were taken for 2 
minutes and at every 15 minutes up to a 2-hour duration during the 
reaction. In an aqueous solution, CuCl2 dissociates into Cu2+ and Cl- ions 
and after addition of surfactant sodium dodecyl sulphate (SDS), forms a 
complex with SDS. Figure 0-4 a and b show UV-visible absorbance 
spectra from aqueous solutions of CuCl2 and Au nanorods, respectively. 
CuCl2 was found to possess its absorption band at a peak wavelength of 
791 nm whereas Au nanorods were observed to exhibit an absorption 
band at 510 nm, however, the major absorption band was found to occur 
at a peak wavelength of 730 nm. As Au nanorods were already with 
cationic capping agent CTAB, after addition of Au nanorods, anionic SDS 
and cationic CTAB bind each other electrostatically, enabling the 
deposition of Cu-SDS complex on the surface of gold nanorods[209]. The 
Cu2+ ions that were already in the solution may get attached to the 
surfactants on the surface of the Au nanorods. As CuCl2 used in the 
reaction was of very low in concentration, the absorbance spectra from 
the mixture of CuCl2, SDS and Au nanorods was at 720 nm which is 
predominantly from Au nanorods (Figure 0-4 c2). In the mixture of CuCl2, 
SDS and Au nanorods, Cu(OH)2 forms slowly on the surface of Au 
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nanorods while adding NaOH. However, there was no noticeable change 
in the UV-visible absorbance spectra (Figure 0-4 c3).   
 
Figure 0-4: UV-visible spectra of (a) CuCl2 and (b) Au nanorods. (c) Normalised 
data showing the changes in UV-Visible absorbance spectra during the 
formation of shell on Au nanorods. (c1) is the UV-visible spectra of CuCl2 as 
shown in (a). (c2) is the spectra of the mixture of CuCl2, SDS and Au nanorods, 
(c3) is the spectra of the aqueous solution after adding NaOH into the solution 
for (c2) and (c4) is the spectra of the aqueous solution after mixing NH2OH.HCl 
into the solution of (c3). After adding NH2OH.HCl a significant blue shift was 
visible which is may be due to the formation of a thin layer of Cu2O on nanorods. 
Afterwards, UV-visible spectra were taken every 15 minutes (c5-c11) and also 
after washing with milli-Q water three times by centrifuging at a maximum RCF 
of 6700 ×g for ten minutes each, then redispersed in milli-Q water (c12). The 
two grey boxes here showing positions of the peaks. 
 
A remarkable change occurred after the addition of NH2OH.HCl in the 
mixture and within 2 minutes, a relatively sharp UV-visible absorbance 
spectrum was observed, at around 580 nm and this absorption peak 
remained for the next 15 minutes. This change happens due to the 
reduction reaction between NH2OH.HCl and Cu(OH)4 which may form a 
very thin layer of Cu2O[208] on the surface of Au nanorods. After 30 
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minutes, the reaction reached an equilibrium state and the absorption 
maxima were slightly red-shifted to 595 nm which remained the same for 
up to 2 hours of reaction. After 2 hours of reaction, the Au(rods)@Cu2O 
core/shell nanoparticle solution was centrifuged at a maximum RCF of 
6700 ×g for ten minutes and the resultant pellet was washed with milli-Q 
water. This centrifugation and washing with water were repeated three 
times to remove excess surfactants and other counterions.  
 
This systemic study helped to understand how the addition of a thin layer 
of Cu2O on Au nanorods can influence the surface plasmon resonance 
absorption properties from Au nanorods. This phenomenon was observed 
when the presence of semiconductors is in close proximity of the metallic 
structures in hybrid materials. Plasmonic features of the hybrid 
nanoparticles can be modified as a result of plasmon-exciton coupling[99-
102]. This relatively rapid reaction process can result in even thinner 
layers which may give even different optical properties. Depending on the 
desired application, the absorption properties of Au(rods)@Cu2O 
core/shell can be tailored through following a similar process as outlined 
in the section.  
The influence of the plasmonic properties of the gold nanorods on the 
fluorescent properties of the Cu2O shell was then studied by collecting the 
fluorescent spectral data and imaging the emission using a confocal 
fluorescent microscope.  
Fluorescent spectral data was collected from Au nanorods and 
Au(rods)@Cu2O core/shell nanoparticles using a supercontinuum pulsed 
 106 
 
laser at a wavelength of 520 nm (2.38 eV) with an FWHM = 10 nm and 
repetition rate of 80.00MHz with 20 µW average excitation power (6.55E-
10 W/cm2) at room temperature.  Figure 0-5 (a and b) shows the 
fluorescent spectral data and confocal images from Au(rods)@Cu2O 
core/shell nanoparticles after 2 hours of reaction, respectively. Under 
these excitation conditions, there were two emission bands from Au 
nanorods at around 587 nm (minor peak) and 684 nm (major peak) (Figure 
0-5 a). 
 
Figure 0-5: Fluorescence spectra of ensemble Au nanorods (a) and 
Au(rods)@Cu2O core/shell nanoparticles (c). Here the different colour of the 
spectra corresponds to the different regions on the confocal maps of the same 
sample. These data were taken using 520 nm supercontinuum pulsed laser with 
20 µW average excitation power (6.55E-10 W/cm2) at room temperature with an 
FWHM = 10 nm. Fluorescence spectra of Au nanorods had been blue shifted 
due to exciton-plasmon interactions after Cu2O shell formation on Au nanorods. 
High-resolution confocal fluorescence image of Au nanorods (b) and 
Au(rods)@Cu2O core/shell nanoparticles (d). 
 
 107 
 
However, after Cu2O shell formation on the surface of gold nanorods, 
Au(rods)@Cu2O core/shell nanoparticles appear to exhibit only one 
strong emission centred at 590 nm (Figure 0-5 c). This emission possibly 
originates from the Cu2O shell, however, the position of the emission may 
be influenced by the presence of Au nanorods themselves. As it has been 
reported that peak broadening or shift can happen in case of metal-
semiconductor hybrids due to plasmon-exciton interactions[93]. This 
emission wavelength is also different from the emission wavelength from 
single Cu2O nanocubes which was at 754 nm with 520 nm excitation[37]. 
This is may be due to the size of the Au(rods)@Cu2O core/shell 
nanoparticles is more than three times smaller than the size of the Cu2O 
nanocubes[37, 210]. Figure 0-5 (b) and 5.5(d) show confocal fluorescence 
maps of Au nanorods and Au(rods)@Cu2O core/shell nanoparticles using 
same excitation wavelength as in Figures 5-5 (a) and (c) which was 520 
nm. The ability to tune the emission wavelength through the fabrication of 
hybrid Au(rods)@Cu2O core/shell nanoparticles has the potential be 
helpful for biological imaging applications that require a range of visible to 
near-infrared wavelength emission from a similar fluorescent probe. 
Emission brightness and the photostability are two representative 
parameters used to characterise the fluorescent semiconductor 
nanoparticles. Figure 0-6 a and b shows, brightness and photostability 
collected from the Au nanorods and Au(rods)@Cu2O core/shell 
nanoparticles, respectively. Brightness and photostability data were 
collected using the laser having the 520 nm excitation wavelength with 20 
µW average power with FWHM = 10 nm for 30 minutes. Emission counts 
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were observed between 39.8k and 41.1k counts/s for Au nanorod (Figure 
0-6 a) whereas emission counts for Au(rods)@Cu2O core/shell 
nanoparticles ranged between 50k and 53.9k counts/s for typical particles 
(Figure 0-6 b). 
 
Figure 0-6: Fluorescence intensity of the Au nanorods (a) and Au(rods)@Cu2O 
core/shell nanoparticles (b) over a 30 minutes time period of continuous 
excitation with 20 μW time-averaged power at the sample from the 
supercontinuum pulsed laser. Here the different colour of the spectra 
corresponds to the different regions on the confocal maps of the same sample. 
Although initial the emission intensity of the Au(rods)@Cu2O core/shell 
nanoparticles was 10k higher than the emission intensity of the Au nanorods,   
in this 30 minutes period, nanorods remained stable whereas the emission 
intensity of the Au(rods)@Cu2O core/shell nanoparticles reduced by around 
12 %. However, compared to some other commercially available organic 
fluorophores this emission intensity reduction over a 30 minutes time period is 
remarkably low[52]. 
 
Although Au nanorods remained stable for a period of at least 30 minutes, 
a 12 % emission count reduction was seen in case of Au(rods)@Cu2O 
core/shell nanoparticles over the time period of 30 minutes.  However, it 
should be noted that this emission intensity reduction over a 30 minutes 
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time window is remarkably low compared to some popular commercially 
available organic fluorophores[52]. It also should be mentioned that the 
laser power used in this section of the research was significantly lower 
than that typically used in some biological imaging applications[133]. The 
relationship between excitation power and initial emission counts was also 
studied on Au nanorods and Au(rods)@Cu2O core/shell nanoparticles 
using 5 excitation powers (Figure 0-7). 
 
Figure 0-7: Fluorescence emission intensity of the ensemble Au nanorods and 
Au(rods)@Cu2O core/shell nanoparticles that were drop cast and dried on a 
Si wafer was measured under 1 μW, 5 μW, 10 μW, 15 μW and 20 μW 
excitation power. After 12 µW excitation power, the emission rate increases for 
Au/ Cu2O core/shell nanoparticles compared to the emission rate of Au 
nanorods.  This result suggests a possible fluorescence enhancement of Au 
nanorods as a result of exciton-plasmon coupling in Au(rods)@Cu2O 
core/shell nanoparticles.   
 
Up to a value of 5 µW excitation power, the emission intensity increases 
linearly with increasing excitation power for both types of nanoparticles. 
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However, for 10 µW excitation power and higher excitation powers, the 
emission intensity was observed to increase at a greater rate for the 
Au(rods)@Cu2O core/shell nanoparticles compared to than that of the Au 
nanorods alone. As has been previously reported, photoluminescence 
characteristics and optical responses of semiconductors can be improved 
by the metallic components in case of metal-semiconductor hybrids[96, 
97, 101]. This result suggests that this enhancement in emission intensity 
is likely due to the formation of Cu2O shell on Au nanorods. 
 
Another representative parameter for any fluorescent biomarker is 
photostability, as the stability of commercial organic fluorophores typically 
decreases over time under light excitation. Therefore, a comparison was 
made for the photostability of the Au nanorods, Au(rods)@Cu2O 
core/shell nanoparticles and few commercially available fluorescent 
probes which are presented in Figure 0-8. It has previously been reported 
that Alexa Fluor 647, polyacrylonitrile beads and carbon dots which are 
some of the commercially available fluorescent probes, bleach quickly 
which eventually limits their application for long-term bioimaging 
studies[52].  
Photostability of Au nanorods and Au(rods)@Cu2O core/shell 
nanoparticles were compared with photostability of Alexa 647, 
polyacrylonitrile beads, Au nanoclusters, Carbon dots, Nanodiamonds 
and Nanorubies for two minutes[52]. Photostability of Au(rods)@Cu2O 
core/shell nanoparticles were the highest (100%) which is similar to Cu2O 
nanocubes, nanodiamonds and nanorubies whereas Alexa 647 showed 
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lowest photostability (2 %) followed by Au nanoclusters (24 %) and 
polyacrylonitrile beads (39 %) (Figure 0-8) compared to the above-
mentioned fluorescent probes (Figure 0-8). From a photostability point of 
view, this result suggests this material is suitable for long-term biological 
imaging applications.  
 
Figure 0-8: Comparison of the photostability of Au nanorods (a) and Au/ Cu2O 
core/shell nanoparticles (b) with commercial dyes and emerging fluorescent 
nanoparticles over a time period of 120 seconds (c). The photostability of Cu2O 
nanocubes is 98% higher than the widely used commercial Alexa 647 dye and 
48 % higher than carbon dots (c). Au nanorods and Au/ Cu2O core/shell 
nanoparticles are showing 100% photostability over this time period which is 
similar to the photostability of Cu2O nanocubes, nanorubies and nanodiamonds 
(c). 
 
The following section of this chapter discusses a potential biological 
application for Au(rods)@Cu2O core/shell nanoparticles. Au(rods)@Cu2O 
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nanoparticles have been introduced to fixed cumulus-oocyte complexes 
to determine whether Au(rods)@Cu2O core/shell nanoparticles can be 
distinguished above background signals from the cumulus-oocyte 
complexes (Figure 0-9).   
 
Figure 0-9: The bright field image of Au(rods)@Cu2O core/shell nanoparticles 
on cumulus-oocyte complex (a and b). The images were taken using an 
Olympus upright microscope where Au(rods)@Cu2O core/shell nanoparticles 
are visible as greenish orange coloured aggregation. Confocal fluorescence 
image of a mouse cumulus-oocyte complex with Au(rods)@Cu2O core/shell 
nanoparticles (c). Blue spots in the orange boxed region are Au(rods)@Cu2O 
core/shell nanoparticles. d) Histogram showing the relative brightness of 
autofluorescence (blue bars) and Au(rods)@Cu2O core/shell nanoparticles 
fluorescence (orange bars). The autofluorescence histogram shows the 
distribution of pixel intensities within the white boxed region in (c). The 
Au(rods)@Cu2O core/shell nanoparticles histogram shows the brightness 
distribution of 20 manually selected spots of Au(rods)@Cu2O core/shell 
nanoparticles in (c). Autofluorescence from the mouse cumulus-oocyte complex 
was observed to be approximately 3 times higher in intensity than the 
Au(rods)@Cu2O core/shell nanoparticles hence making them easily 
distinguishable as they can act as a contrast agent for fluorescence imaging 
applications. 
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Figure 0-9 (a) and Figure 0-9 (b) shows the bright field image of a mouse 
cumulus-oocyte complex with Au(rods)@Cu2O core/shell nanoparticles 
that was imaged under an Olympus upright microscope where 
Au(rods)@Cu2O core/shell nanoparticles are visible as greenish orange 
coloured aggregates as they emit within a 550 nm-750 nm spectral 
window. This result suggests that Au(rods)@Cu2O core/shell 
nanoparticles are also could be easily visible with low-resolution 
brightfield microscopes. Figure 0-9 (c) shows the confocal image of the 
same Au(rods)@Cu2O core/shell nanoparticles that have been introduced 
to fixed cumulous oocyte complex imaged with the same experimental 
conditions (520 nm supercontinuum pulsed laser with 20 µW average 
excitation power (6.55E-10 W/cm2) and 80.00 MHz repetition rate at room 
temperature with an FWHM = 10 nm) used for optical characterization of 
ensemble Au(rods)@Cu2O core/shell nanoparticles. The fluorescence 
emission of the Au(rods)@Cu2O core/shell nanoparticles were compared 
to the autofluorescence within the mouse cumulus-oocyte complex (Figure 
0-9 c and 5.9d). The blue areas on the surface of the mouse cumulus-
oocyte complex correspond to the fluorescence emission from 
Au(rods)@Cu2O core/shell nanoparticles. The histogram in Figure 0-9(d) 
shows the relative brightness of autofluorescence from the mouse 
cumulus-oocyte complex compared to Au(rods)@Cu2O core/shell 
nanoparticles fluorescence. The autofluorescence histogram collected 
from the distribution of pixel intensities within the boxed region in Figure 
0-9(c) and the Au(rods)@Cu2O core/shell nanoparticles histogram (Figure 
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0-9(d)) shows the brightness distribution of 20 manually selected regions 
where Au(rods)@Cu2O core/shell nanoparticles were present in Figure 
0-9(c). Compared to the fluorescence from Au(rods)@Cu2O core/shell 
nanoparticle, autofluorescence signal from the cumulus-oocyte complex 
was three times higher in intensity. This characteristic made them easily 
distinguishable from autofluorescence which can act as a contrast agent 
for fluorescence imaging applications (Figure 0-9c and Figure 0-9 d).  The 
attractive characteristics of Au(rods)@Cu2O core/shell nanoparticles, 
such as their long photostability, fluorescence and plasmonic properties, 
visibility with low-resolution bright field microscope and highlight their 
potential as to act as a future alternative to commercially available 
fluorescent probes for bioimaging applications. 
 
5.4 Conclusion 
In conclusion, hybrid materials consisting of gold nanorods and Cu2O 
shell material were prepared with the objective to combine the plasmonic 
advantages of gold nanorods and the intrinsic fluorescent properties of 
Cu2O. 25 nm-thick shells of Cu2O were controllably deposited on the 
surface of 40 nm long gold nanorods and these nanoparticles were found 
to have a uniform size. The formation of Au(rods)@Cu2O core/shell 
nanoparticles were followed by UV-visible spectroscopy and a 
mechanism of formation was proposed. The addition of SDS and NaOH 
led to the deposition of Cu(II) ions and precipitation as Cu(OH)2 on the 
surface of gold nanorods, respectively. Subsequent addition of 
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hydroxylamine reduces the as-formed Cu(OH)2 to Cu2O shell. This was 
confirmed from a large blue shift of UV-visible absorption maxima due to 
Cu2O shell formation on Au nanorods compared to the bare nanorods. 
Au(rods)@Cu2O core/shell nanoparticles are highly photostable 
compared to the other commercially available fluorophores. The 
fluorescent emission intensity of Au nanorods was also found to increase 
due to the formation of the Cu2O shell. These nanoparticles are easily 
visible under the low-resolution bright field microscope and effortlessly 
distinguishable from autofluorescence of mouse cumulus-oocyte complex 
under a confocal microscope. Therefore, hybrid materials consist of metal 
core and semiconductor shell can combine the advantages of the 
plasmonic properties of metal and fluorescent properties of the 
semiconductors
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 Conclusion 
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6.1 Summary of the work 
The emerging area of biophotonics requires the development of bright and 
photostable fluorescent probes as currently available fluorescent probes have 
several limitations. To address those limitations, the inorganic semiconductor 
nanomaterial Cu2O was synthesised and investigated in this research. Cu2O, a 
p-type semiconductor, was synthesised following a seed-mediated approach. 
Two major modifications were made in the synthesis process to achieve 
monodispersity and increased yield. In the first modification, the ageing time of 
the Cu2O seeds was increased to create nanocubes with uniform morphology. 
In the second modification, the reactant volume and concentration were 
increased to obtain a higher yield. Without the need for any additional chemicals 
to the process, the yield and size of the Cu2O nanocubes have been achieved 
in a controlled manner.  This was accomplished by determining the key 
parameters involved in controlling the yield and morphology of Cu2O 
nanocubes.  
The optical properties of single and ensemble Cu2O nanocubes have also been 
studied.  Cu2O nanocubes exhibit bright NIR I emission with visible excitation 
wavelength.  The emission wavelength can also be tuned to some degree 
through controlling the temperature. These nanoparticles are highly bright with 
low power excitation and they are also highly photostable for an extended period 
of time. Emission intensity from these nanoparticles was the highest with 400 
nm to 600 nm excitation wavelength at room temperature and with the same 
excitation power emission intensity increases with the decrease of the 
temperature. Since the Cu2O nanocubes exhibit high brightness in the NIR-I 
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biological window, with relatively low power excitation, these nanoparticles have 
the potential to be an alternative to commercially available fluorophores for long-
term biological imaging applications without the requirement for additional 
fluorescent tags to be added to the nanocubes.  
In the study of the cytotoxicity of the Cu2O nanocubes, two types of tests were 
performed. Cell viability was tested using a Neutral red assay and a cytotoxicity 
study was performed using a Lactate dehydrogenase (LDH) assay on BV2 cells 
and HEK293 cells. The cell viability study, using Neutral red assay, showed that 
the concentration of nanoparticles did not significantly influence the cell viability 
regardless of cell type. Although HEK293 cells did not exhibit any significant 
concentration-dependent increase in LDH activity at any time point, for BV2 
cells, LDH activity largely increased when the concentration was either 2 µg/mL 
or 4 µg/mL of Cu2O nanocubes over 24 hours. This study suggests that not all 
cell types show cytotoxicity towards Cu2O nanocubes and for phagocytic BV2 
cells, nanoparticles concentration can be as high as 4 µg/mL over a 2-hour time 
window. Whereas, for long-term studies over 24 hours, it was determined that 
less than 500 ng/mL Cu2O nanocubes can be used without having an effect.  
In the area of reproduction biology, after introducing Cu2O nanocubes to a 
mouse oocyte complex, studies show that there is no sign of photobleaching for 
Cu2O nanocubes even after 2 hours of continuous imaging with a commercial 
confocal microscope.   These nanoparticles are highly photostable compared to 
many other commercially available organic fluorophores and nanomaterials and 
open the possibility to study photocatalytic and angiogenesis processes in 
biology over an extended period of times. 
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The final component of this thesis explored the combination of the plasmonic 
gold nanorods, as a core, and the fluorescent properties of Cu2O, as a shell to 
make a hybrid nanomaterial.  The hybrid nanomaterials were found to exhibit a 
25 nm thick shell of Cu2O surrounding or on the surface of 40 nm-long gold 
nanorods. Significant changes in the UV visible spectra were observed during 
the formation of the Au(rods)@Cu2O  hybrid nanomaterials and a mechanism 
of formation was proposed. A blue shift of UV-visible absorption maxima and an 
increase of brightness was also observed compared as the Cu2O shell was 
formed on the Au nanorods as compared to the bare Au nanorods. 
Au(rods)@Cu2O  core/shell nanoparticles are highly photostable compared to 
the other commercially available fluorophores, easily visible under low-
resolution bright field microscope and effortlessly distinguishable from 
autofluorescence of mouse cumulus-oocyte complex under a confocal 
microscope. This Au(rods)@Cu2O  core/shell nanoparticles can work as 
multifunctional nanoparticles as they consist of metal core and semiconductor 
shell combining the advantages of the plasmonic properties of metal and 
fluorescent properties of the semiconductors. 
 
6.2 Scope for future work   
This thesis introduced Cu2O nanoparticles and Au(rods)@Cu2O core/shell 
nanoparticles for a biological imaging application. However, this thesis did not 
describe the way of introducing these nanoparticles for biological imaging. 
Research can be conducted to bioconjugate these nanoparticles with different 
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crosslinkers for cellular imaging, diagnostic purposes or to target specific 
molecules.  
Another way of using these nanoparticles in different cell imaging and 
diagnostic is forming the polymers or silica shells on the surface of those 
particles that have been readily used in these fields. As silica nanoparticles and 
polymers are widely used for the assays or detection strategies for bio 
application purposes[211], forming silica or polymer shell on the surface of this 
nanoparticles can remarkably combine the fluorescent properties of the 
nanoparticles and the diagnostics properties or the properties for targeting 
specific molecules of silica or polymers[20, 212, 213]. As a result, these 
nanoparticles can be used in different field of bioimaging and diagnostics using 
existing protocol for silica or polymers. 
As the emission wavelength and emission intensity of these nanoparticles 
highly depend on the temperature, fluorescent based temperature sensor also 
can be developed using these nanoparticles. 
Cytotoxicity study needs to be performed on Au(rods)@Cu2O core/shell 
nanoparticles to use it as a fluorescence tag for biological applications as it has 
the advantages of the plasmonic properties of metal and fluorescent properties 
of the semiconductors.      
Further study needs to be done to determine the concentration of Cu2O 
nanoparticles and Au(rods)@Cu2O core/shell nanoparticles requires for 
biological imaging applications. 
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